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Numerous pathologies that affect the urinary bladder, such as spinal cord injury (SCI), 
bladder outlet obstruction, or diabetes, cause bladder wall remodeling. Bladder remodeling is 
marked by changes in the extracellular matrix (ECM) proteins collagen and elastin as well as 
alterations in bladder smooth muscle cell (BSMC) hypertrophy and phenotype. Previous work 
has examined the bladder following SCI and found an early increase in elastin and hypertrophy 
followed by longer term fibrosis. These studies indicated that the mediating factor in bladder 
remodeling in response to early stage SCI and other pathologies such as obstruction and diabetes 
is strain. In the SCI bladder, the strain history is changed from normal filling and voiding to over 
distension and intermittent smooth muscle cell contraction. The goals of this study were to utilize 
an ex vivo organ culture model to examine the effects of strain on bladder smooth muscle 
remodeling, examine the effects of TGF-ß1, found to be up regulated in the SCI bladder, and to 
utilize a tissue engineering methodology to examine the effects of strain in cell-seeded biologic 
scaffolds. The first aim from this study showed that abnormal strain frequency profoundly 
induces elastogenesis in the ex vivo bladder. Further examination with the addition of TGF-ß1 
with and without mechanical stimulation showed that mechanical stretch of the ex vivo bladder 
mimics the early stage SCI bladder in remodeling and cell phenotype, and the addition of TGF-
ß1 alters this phenotype. Additionally, it was found that TGF-ß1 added to culture of BSMC on 
collagen gels decreases gel contraction but increases collagen organization of the gels. Finally, in 
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a tissue engineered construct it was found that the growth factors VEGF and FGF-2 promote 
penetration of BSMC into small intestinal submucosa and that strain frequency alters the ECM 
proteins that the BSMC produce with a frequency of 0.1 Hz promoting elastogenesis and a 
frequency of 0.5 Hz promoting collagen production. The information gained in this study gives 
further insight into the role of strain in pathological remodeling of the bladder, and it provides a 
basis for tissue engineering constructs with controlled BSMC penetration and ECM composition.  
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1.0  INTRODUCTION 
1.1 THE URINARY BLADDER 
The urinary bladder is a hollow organ that sits on the pelvic floor muscles behind the pelvic 
bone. The urinary bladder’s main function is to store large volumes of urine that flow to the 
bladder from the kidneys through the ureters. When the bladder is full, the bladder voids with a 
coordinated smooth muscle contraction with a simultaneous relaxation of the urethral sphincter. 
When this simultaneous contraction and relaxation occurs, urine flows from the bladder through 
the urethra out of the body. The urinary bladder, while seemingly a simple hollow organ, is 
composed of several different layers containing many cell types and extra cellular matrix (ECM) 
proteins that contribute to maintaining the bladder’s normal function. 
1.1.1 Bladder layers and cell types 
The layers of the bladder wall are: the mucosa, submucosa, detrusor, and adventitia (depicted in 
Figure 1-1).  Each of these layers provides both a biological and biomechanical function. The 
most interior layer of the bladder is the mucosa. The mucosa contains both the transitional 
epithelium and the lamina propria. The transitional epithelium or urothelium contains a 
superficial layer of umbrella or flat cells with a deeper layer of columnar and cuboidal cells that 
function together to create a barrier to urine, maintain the urine composition, and facilitate 
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voiding. The umbrella cells provide an initial barrier to urine and are covered with a 
glycoseaminoglycan (GAG) layer (Figure 1-2) [1].  The umbrella cells have the ability to change 
surface area dramatically and are the largest epithelial cells in the body, ranging up to 200µm in 
diameter. They may also be multinucleate and possess maintain a large pH gradient from the 
urine to the plasma within the cell. The differentiated urothelium expresses uroplakins that may 
be used as cellular markers to discriminate urothelial cells from other epithelium. 
 
 
Figure 1-1. The urinary bladder. Reprinted from academic.kellogg.cc.mi.us/herbrandsonc/bio201 . 
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Figure 1-2. Urothelial organization. Reprinted from [1]. 
 
The lamina propria interior to the urothelial lining is a membrane consisting of a dense 
ECM with nerves, blood vessels, glands, and myofibroblast cells. The ECM of the lamina 
propria is composed mainly of collagen types I, III and IV with some elastin interspersed 
throughout. A previous study has suggested that the lamina propria is responsible for bladder 
compliance at the early and late stages of bladder filling [2]. Among the cell types associated 
with blood vessels (vascular smooth muscle cells and epithelium), innervation, and lymphatic 
glands, the prominent cell type in the lamina propria is the myofibroblast. Until recently, the 
suburothelial myofibroblast was poorly understood; however, there is now more concrete 
evidence that the myofibroblast plays a valuable role in communication between the urothelium 
and the detrusor smooth muscle. The myofibroblasts lie in rows under the urothelium and have 
alignment and projections parallel to the urothelium [3]. The myofibroblasts are the main place 
in the bladder where the gap junction protein connexin 43 (Cx43) is found co localized in cells 
with positive staining for vimentin in this region of the bladder. The general understanding of the 
 4 
myofibroblasts function is that they form part of a sensory response to filling that cause the 
urothelium to release transmitters [3].  
Exterior to the mucosal layer of the bladder is the detrusor layer. The detrusor is 
comprised of bundles of detrusor smooth muscle cells, referred to in the present study as bladder 
smooth muscle cells (BSMC). These muscular bundles are organized in 2 layers in the rat 
bladder and 3 layers in the human bladder. In the human bladder, the smooth muscle bundles in 
the outer and inner layers are arranged longitudinally and the middle layer is arranged 
circumferentially [4]. These layers are depicted in Gray’s anatomy Figure 1-3.  
 
 
Figure 1-3 . Layers of the urinary bladder wall. Reprinted from [5].  
 
Each muscle bundle within the detrusor is surrounded by collagen and a thin layer of 
elastin. The surrounding ECM is composed of mainly collagen with some elastin in a matrix of 
proteoglycans [1]. The ECM in the detrusor has been shown to change in composition in 
pathological states. In spinal cord injury, our laboratory has found previously that elastin and 
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collagen content is altered within the detrusor [6]. Changes in the ECM content within the 
detrusor ultimately affect the biomechanical properties of the bladder wall. Following SCI, the 
viscoelastic properties of the bladder wall change due to corresponding changes in ECM [7]. 
Other studies of bladder outlet obstruction have shown similar changes in the ECM within the 
detrusor. However, it has not been shown conclusively that changes in biomechanical properties 
following these pathologies is due to the changes in the ECM alone or in combination with the 
detrusor smooth muscle bundles. 
The smooth muscle in the bladder contains actin and myosin scattered throughout the 
cell, not in a sarcomeric pattern as in skeletal muscle. The smooth muscle in the bladder must 
regularly undergo immense length changes that are not matched anywhere else in the body. It is 
the arrangement of the contractile machinery in the smooth muscle that allows for this immense 
length change [8, 9]. The smooth muscle maintains a tone that can be modulated with 
pharmacologic agents. The smooth muscle excitation/contraction coupling is shown in Figure 1-
4. The detrusor muscle also has the ability to generate contractile force without external stimuli 
through the electrical coupling between BSMCs. The muscle exhibits spontaneous rhythmic 
activity witnessed both in vitro and in vivo [4]. Under pathological conditions such as 
obstruction or spinal cord injury (SCI), these cell-cell interactions may be disrupted causing 
changes in transmission of excitation leading to hypertrophy and dysfunction of the bladder [10].  
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Figure 1-4. Depiction of BSMC contraction through shortening. [1]. 
 
The BSMCs themselves are characterized by expression of specialized contractile 
machinery found specifically in smooth muscle. The precise arrangement of thin actin filaments 
and thicker myosin filaments has not been fully characterized in smooth muscle [4]. There are 
four different isoforms of actin expressed in smooth muscle α- , ß-, and two isoforms of γ- actin. 
The most prominent of these isoforms in rat and human are α- and γ- actin [4]. The functional 
roles of these actin isoforms are unclear at present and are an area of future research. Alpha-
smooth muscle actin (α –SMA) is commonly used as a marker of smooth muscle cells as it is 
predominately found in smooth muscle, but it also may be located in fibroblasts and 
myofibroblasts under pathological conditions in multiple organs, such as heart valve leaflets, 
vascular networks, the airway, and liver among others. Probably the most important contractile 
protein in the BSMC crucial to proper function is myosin. There exists 3-5 times less myosin in 
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smooth muscle than in skeletal muscle, and the ratio of actin to myosin is approximately 15:1 
[4]. Smooth muscle myosin is in the myosin II superfamily of myosin motors [11]. The myosin 
molecule is formed with two heavy chains and two pairs of light chains. The inserted heavy 
chain myosin isoform, SM-B, is expressed highly in the urinary bladder and is responsible for 
the bladder smooth muscle being a relatively fast smooth muscle type  [12] . The myosin heavy 
chains are generally thought to be responsible for contractile kinetics in bladder smooth muscle, 
but it is thus far unknown exactly how these heavy and light chains interact with the entire 
cytoskeletal structure. In addition to the muscle myosin, smooth muscle can also express non-
muscle myosin heavy chain (NM-MHC). These chains are not heavily expressed in the adult, and 
have been shown to be important in development, migration, and proliferation of the BSMC in 
culture [13]. Additionally in the contractile domain of the cytoskeleton, there are dense bodies 
that are associated with a network of the intermediate filaments. The intermediate filaments are 
mainly composed of desmin and vimentin. The urinary bladder in rat and humans contain 
predominantly desmin filaments [4]. Other contractile proteins of interest commonly used as 
markers for smooth muscle, are caldesmon (CaD) and calponin. CaD is bound to thin filaments 
and interacts with tropomyosin, myosin, and calmodulin [4]. CaD has been found to stabilize 
actin as well as intermediate filaments [14]. There are two isoforms of CaD: h-CaD (high 
molecular weight) and l-CaD (low molecular weight). H-Cad is specific to smooth muscle cells. 
The l-CaD is present in nonmuscle cells, although it is present in small amounts within smooth 
muscle [14]. In longer-term BSMC culture as well as in the hypertrophic bladder the l-CaD 
content increases. It is for this reason that the present study utilized BSMC prior to passage 10 in 
culture. It is thought that the l-CaD protein is important in regulating cell division, migration, and 
shape changes [14]. The protein calponin is also associated with actin filaments and is localized 
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in both the contractile and cytoskeletal domains of the smooth muscle cells [15]. It has been 
shown in assays to inhibit contractions and filament sliding [4]. The contractile sequence of the 
BSMC is as follows:  
 1. Ca2+ binds to calmodulin, activating it.  
 2. Calmodulin activates the kinase enzyme. 
3. Kinase enzyme catalyzes phosphate transfer from adenosine triphoshate to 
myosin, allowing myosin to interact with actin of the thin filaments.  
 4. Smooth muscle relaxes to widen intracellular decrease in Ca2+ levels [1].  
All of the aforementioned contractile and synthetic cytoskeletal proteins serve important roles in 
maintaining the function of BSMC within the detrusor.  
Finally, on the exterior of the detrusor lie an adventitia on one side of the bladder and the 
serosa on the other. The serosa is a peritoneal layer covering the superior surface of the bladder. 
Where there is no serosa, the adventitia covers the rest of the bladder. The adventitia is a loose 
collagenous network interspersed with vasa vasorum [1]. These layers are also surrounded by 
peritoneal fat.  
 
1.1.2  ECM components 
 
The collagen within the bladder wall ECM is composed of primarily collagen type I and III with 
varying ratios among species [16]. Collagen type IV is found in large amounts within the lamina 
propria of the bladder wall [17]. Collagen types I and III surround the smooth muscle bundles 
and make up the majority of the ECM found within the bladder wall. Collagen types I and III are 
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among the five types of collagen that are capable of forming fibrils that can be visualized with 
electron microscopy [18]. The interstitial collagens (including types I and III) are formed through 
cells producing pre-procollagen chains along the rough endoplasmic reticulum that are later 
cleaved within the rough endoplasmic reticulum to form procollagen. Then, lysine and proline 
amino acids on the procollagen are hydroxylated and the glycosylated to form a triple helix 
structure. The procollagen is then moved outside of the cell via exocytosis following packaging 
from the Golgi apparatus. Within the ECM, peptides are cleaved and tropocollagen is formed by 
procollagen peptidase. Then, multiple tropocollagen molecules can form collagen fibrils. 
Multiple collagen fibrils form collagen fibers. Collagen type I is found in most connective tissues 
within the body. Type I and III collagens are capable of forming co-fibrils in many tissues [18]. 
Collagen type III can also form a separate population of thin fibrils. 
In the human bladder, it has reported that the ratio of collagen type I to collagen type III 
is 1:11.1 [16]. However, in the rat bladder there is more collagen type I than collagen type III 
[19]. The concentration of collagen within the bladder becomes altered under pathological 
conditions. In poorly compliant bladders, it has been found that most fibrosis is due to collagen 
type III [20]. Macarak and Howard have performed extensive work on the collagen within the 
bladder [17, 21, 22]. They have suggested that in non-compliant bladders the collagen fibers can 
no longer alter their tortuosity, reducing bladder capacity [22].  In the SCI bladder, collagen 
protein concentration is up-regulated following 2 months after SCI [23]. The diverted sheep 
bladder undergoes smaller bladder capacity with contracted collagen, underlining the importance 
of mechanical stimulation on maintenance of collagen architecture. Alterations in collagen 
content alter the biomechanical properties of the bladder wall, leading to dysfunction. 
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The mechanical role of the collagen during bladder filling and voiding has been explored 
previously. During filling between 0-25%, the lamina propria thins more rapidly than the rest of 
the detrusor indicating that it plays more of a mechanical role during this portion of filling [24]. 
From 25%-50% the detrusor carries the mechanical load, and then from 50%-100% of filling the 
lamina propria again bears the mechanical load [24]. An additional study by Ewalt et al indicated 
that the lamina propria was responsible for normal bladder compliance while changes in collagen 
types I and III within the detrusor were responsible for fibrotic bladder compliance [2]. As the 
lamina propria is made up mostly of connective tissue, the mechanical properties depend on the 
structure of this tissue. Collagen type III has been found in super coils within the lamina propria 
of the bladder [25]. These collagen supercoils appear to uncoil while the bladder is filled proving 
some distensibility; however even at 100% filling the collagen fibers still remain in a coil 
structure (Figure 1-5, [26]). Chang et al. have theorized that the collagen in the bladder exists in 
a hierarchy of folding and coiling beyond simple uncrimping in which large coils of collagen 
fibers are able to accommodate very large strains [25].   The impact of collagen types I and III on 
the biomechanical properties of the bladder wall has further been demonstrated by studies in our 
laboratory wherein biaxial mechanical testing was performed this is described in section 1.2.3. 
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Figure 1-5. Collagen coils during filling. [26]. 
 
Elastic fibers in the bladder are found in all layers of the bladder wall. These elastic fibers 
allow the bladder to recoil to its original shape following distension. Elastic fibers are made up 
of a microfibrillar component and an elastin component (Figure 1-6). The microfibrillar 
component is composed of 5 different proteins predominantly fibrillin, found in forms fibrillin-1 
and fibrillin-2 [27]. Other microfibrils of note are the microfibril associated glycoproteins 1 and 
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2 (MAGP-1 and -2). The elastin component is synthesized in monomer form as tropoelastin, a 70 
kDa protein. Outside of the cell, the tropoelastin monomers are assembled into polymeric form 
within the ECM. The elastin polymers are covalently cross linked together through side chains of 
lysine after oxidative deamination by lysyl oxidase [27]. Figure shows the assembly of elastic 
fibers with an elastic core surrounded by microfibrils. Once assembled into an elastic fiber, these 
fibers may be ordered with the aid of cells (mainly fibroblasts) within the ECM [27]. However, 
the elastin proteins do have the unique ability to self-assemble and conglomerate outside of the 
cell [27].  
It is generally assumed that elastin, once laid down and crosslinked, turns over at a rate of 
less than 1% [28] in any tissue other than the uterus [29]. Elastic fibers making up a large 
majority of ECM in skin, arterial blood vessels, lung paranchyma, and elastic ligaments are 
formed in gestation and in the first year of life with little to no new elastin being produced past 
the first decade [28]. While degradation of elastin is common to many disease states, such as 
vascular disease and uterine prolapse, several organs have been shown to synthesize elastin 
under pathological conditions. In the dermis it has become well accepted that elastin synthesis 
occurs following injury [30].  Elastin synthesis is also observed in the fibrotic liver [31]. In an 
experimental model of liver fibrosis the common bile ducts in the liver are ligated, increased 
tropoelastin and fibrillin synthesis is observed in a rat [30]. It has been demonstrated in the 
inflamed airway, the smooth muscle cells produce large amounts of ECM proteins, including 
elastin [32]. It has also become generally accepted that hypertensive arteries experience a 
thickening in the tunica media as a result of increased elastin synthesis [33]. In the urinary 
bladder, gene expression of tropoelastin and lysyl oxidase were shown to be up regulated in rat 
models of both diabetes [34] and SCI [35]. Elastin has also been observed in obstructed bladders 
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both intra- and inter- fasically in the detrusor [36]. Elastin synthesis following SCI will be 
discussed in the next section.  
 
 
Figure 1-6 Assembley of mature elastic fibers. Reprinted from [37] 
 
The majority of the elastin synthesis that occurs under these aforementioned pathologic 
conditions is presumably in response to mechanical forces on the tissue. The effect of 
mechanical force on ECM production has been examined in a wide variety of cell types and 
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tissues. In development, many of the ECM structures run parallel to the development of cardiac 
pressure, such as has been found in the lamb pulmonary artery [38]. In response to mechanical 
stimulation in vitro, organ culture of pulmonary arteries have produced enhanced elastin 
synthesis in response to sustained mechanical stretch or pressure [38]. Human gingivial 
fibroblasts produced significantly more elastin when mechanically stretched at 1 Hz, 10% strain 
compared to statically cultured cells [39]. Several studies have demonstrated that vascular 
smooth muscle cells produce elastin when seeded on collagen gels or synthetic scaffolds and 
exposed to pulsitile flow and/or mechanical stretch [40]. It should be noted however, that the 
elastin produced by stretching isolated cells and intact tissue is of an amorphous nature, and it 
has been difficult, until the present study, to coax the cells into producing assembled elastin 
fibers in vitro. 
 There are several other ECM proteins in the bladder wall. Laminin and cellular adhesion 
molecules are found abundantly in the submucosa of the bladder [41]. In addition to assisting the 
urothelium in retaining a barrier against urine, the GAGs in the bladder wall are found 
throughout the matrix. The GAGs give the bladder the ability to create a compartment of tissue 
water that allows the bladder to have viscous behavior when deformed during filling [1]. 
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1.2 PHYSIOLOGY AND DISEASE STATES OF THE URINARY BLADDER 
1.2.1 Normal filling and voiding 
Normal filling of the bladder results from peristaltic contractions of the urinary tract which move 
urine produced in the kidney through the ureters into the bladder. These peristaltic contractions 
occur 1-5 times/ minute. The bladder wall smooth muscle relaxes and the urothelial layers and 
ECM matrix stretch as the bladder is filled to accommodate the increasing volume of urine. Once 
the bladder has reached a certain capacity (350-400 mL in humans and 0.7-0.8 mL in rats), a 
signal is sent from urothelial and smooth muscle stretch receptors to the afferent nerves found in 
the mucosal layer of the bladder to the brain. When voiding is to occur, the signal is then sent 
through the efferent nerves to the detrusor which signals the bladder smooth muscle to contract 
(Nerve pathways shown in Figure 1-7). Simultaneously, signals are sent to the pudendal nerve 
causing the urethral sphincter to relax allowing urine to flow out of the body [42]4 #26]. 
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Figure 1-7. Mechanism of storage and voiding reflexes. A, Storage reflexes. During the storage of urine, distention 
of the bladder produces low-level bladder afferent firing. Afferent firing in turn stimulates the sympathetic outflow 
to the bladder outlet (base and urethra) and pudendal outflow to the external urethral sphincter. These responses 
occur by spinal reflex pathways and represent “guarding reflexes,” which promote continence. Sympathetic firing 
also inhibits detrusor muscle and transmission in bladder ganglia. B, Voiding reflexes. At the initiation of 
micturition, intense vesical afferent activity activates the brainstem micturition center, which inhibits the spinal 
guarding reflexes (sympathetic and pudendal outflow to the urethra). The pontine micturition center also stimulates 
the parasympathetic outflow to the bladder and internal sphincter smooth muscle. Maintenance of the voiding reflex 
is through ascending afferent input from the spinal cord, which may pass through the periaqueductal gray matter 
(PAG) before reaching the pontine micturition center.  Reprinted from [1]. 
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1.2.2 Neurogenic disorders 
Neurogenic bladder pathologies can develop as a result of spinal cord injury (SCI), infarction of 
the frontal cortex of the brain such as seen in Parkinson’s disease, or lesions of the nerves of the 
bladder such as seen in Multiple Sclerosis.  Simply put the neurogenic bladder results in 2 
classifications of dysfunction. The first is failure to store urine and the second is failure to empty 
urine. These two modes of dysfunction are caused by 5 different complications, which occur at 
in combination or at different phases depending on the severity of SCI or cause of neurogenic 
bladder [43].  The first complication is decreased sensitization. This results from loss of nerve 
sensation from the bladder causing the inability to stimulate a simultaneous contraction of the 
detrusor to void [43]. This causes urinary retention over time. The second complication is 
hyperreflexia. This occurs when the bladder loses the signal from the brain that inhibits voiding.  
The hyperreflexic bladder contracts frequently even at relatively small volumes.  The third 
complication is hypocontractilty of the detrusor [43]. Hypocontractility occurs when there is 
sensory loss and the brain cannot detect that the bladder is full. The fourth complication is poor 
bladder compliance [43]. When the bladder loses its ability to store urine at low pressures, it 
eventually loses its ability to expand due to many years of central nervous system injury or 
continuous infection and inflammation. The non-compliant bladder can lead to pressure build up 
to over 40 cm H2O which causes severe damage to the kidneys. The fifth complication seen in 
neurogenic bladders is sphincteric dysfunction [43]. This dysfunction often manifests as detrusor 
sphincter dyssynergia wherein the urethral sphincter and bladder contracts simultaneously.  
Additionally, sphincter dysfunction may manifest as intrinsic sphincter dysfunction which may 
be the result of previous sphincter injury [43]. 
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 In the U.S. alone approximately 11,000 new people suffer from spinal cord injury (SCI) 
each year.  As mentioned above, SCI  rostral to the lumbar spine can lead to severe lower urinary 
tract dysfunctions including bladder outlet obstruction and detrusor instability [44]. In addition to 
the functional deficiency, these bladder dysfunctions are often accompanied by changes in the 
wall tissue morphology such as hypertrophy [45], trabeculation [46], and fibrosis [47] as well as 
by significant changes in the mechanical properties of the wall [48-50].   The majority of these 
SCI patients develop urologic complications, which include urinary retention (due to incomplete 
voiding) and overactive bladders (due, for example, to abnormal neurogenic inputs and/or 
alteration in myogenic functions) [44, 51-53]. It has also been reported in the literature that these 
neurogenic bladders develop hypertrophied and/or fibrotic walls and that compliance of the 
bladder is significantly altered in the chronic SCI patients compared to normal individuals [47, 
50].  These findings suggest that there may be strong correlations between the tissue 
morphology, mechanical properties of the wall and the health state of the bladder.   
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Figure 1-8. Histological sections from normal and SCI rat bladders stained using the Movat’s pentachrome.  
Compared to normal (Frame A), the SCI rat bladder (Frame B) was much thicker and contained more smooth 
muscle (stained in red).  Although comparable amounts of collagen (stained in yellow) were present in the sections 
of both   normal (Frame C) and SCI (Frame D) bladders, there were significantly more elastic fibers (stained in 
black; indicated by arrows) in the SCI bladder. Mags.= 10X (Frames A, B); 40X (Frames C, D). From Nagatomi et 
al. [54] 
 
 Our laboratory has shown previously that biaxial mechanical testing methods can be 
successfully applied to the normal and SCI rat bladder wall [55].  Our mechanical studies have 
demonstrated that the bladder wall exhibits complex biomechanical behaviors that are 
profoundly altered post-SCI. In particular, we have observed that during the initial areflexic 
phase of SCI, the UBW undergoes profound remodeling to compensate for increased wall stretch 
from over-distension.  This is then followed by a hyper-reflexic phase in which the UBW further 
alters its structure and mechanical behavior, primarily through changes in smooth muscle 
function and collagen content, resulting in an eventual stiffening of the UBW and reduced 
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bladder compliance.  The stimuli for these profound functional changes are presumably due to 
differing mechanical stimuli; large tissue strain during areflexia and increased tissue stress 
during hyper-reflexia. The biomechanical changes are thus a direct result of rapid and profound 
bladder wall tissue remodeling, including changes in smooth muscle cell orientation, collagen 
and elastin concentrations [7, 55-57]. Figure 1-8 depicts the severe hypertrophy and elastin 
deposition what occurs in the SCI affected bladders. 
1.2.3 Obstructive and congenital disorders 
Bladder wall remodeling is also seen in other pathological conditions. Obstruction of the bladder 
neck and urethra usually results from benign prostate hyperplasia in older men, but may result 
from some congenital defects. In bladder outlet obstruction, there are marked changes in bladder 
tissue morphology caused by BSMC hypertrophy and hyperplasia [58]. These changes usually 
result in the inability to store and void urine [59]. Collagen ratio has also been found to be 
decreased in the obstructed bladder due to the large amount of detrusor hypertrophy [1]; 
however, in long term obstructed bladders a fibrotic response is observed with increased collagen 
content [60]. These changes in the bladder structure following obstruction may often be resolved 
when the obstruction is removed, depending on the severity and length of bladder obstruction. 
Bladder exstrophy is the most common congenital abnormality of the bladder. Exstrophy 
occurs when the bladder grows on the exterior of the body which results from a complete ventral 
defect of the urogenital sinus and the overlying inferior abdominal wall musculature and 
integument [61]. This defect results in urine draining into the abdominal wall and inflammation 
of the exposed bladder mucosa. Treatment of exstrophy usually involves extensive surgery on 
the newborn with penile reconstruction and eventual continence in approximately 50% of 
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patients. Prune belly syndrome is a structural abnormality for which the cause is not known. 
Prune belly syndrome results in urine reflux from the bladder which severely damages the 
kidneys [61]. Current management involves repairing the abdominal wall defect and prescribing 
prophylactic antibiotics to prevent rental infection. Functional tissue engineering may provide a 
better reconstructive therapy for the treatment of these abnormalities and will be further 
discussed in section 1.4. 
1.3 EXPERIMENTAL PLATFORMS TO STUDY BLADDER WALL SMOOTH 
MUSCLE IN NATIVE AND REMODELED STATES 
1.3.1 Organ baths and biomechanical testing 
The pathologies discussed in the previous section point out the many areas in which bladder 
dysfunction remain poorly understood. Several studies to date have focused on understanding the 
many aspects of bladder wall function with in vitro techniques.  At the organ level, whole 
bladders may be isolated and pressure measurements may be recorded to determine intravesical 
pressure and wall stress estimated via the Law of Laplace. Although, often interpreted as a 
contractility measure, the intravesical pressure does not provide accurate information about the 
contractility of the smooth muscle [62].  
 Alternatively, there exist a number of studies on bladder smooth muscle contractility 
performed at the tissue level using organ baths, wherein a strip of tissue is suspended in a 
physiological solution with one end fixed and the other attached to a load in order to measure 
isotonic contraction under a variety of conditions. Problems arise in the tissue strip studies 
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mostly due to the set up of the experiments, such as sample size issues, diffusion of chemical 
agents, and the mode of attachment of sample to transducer [63]. While these studies continue to 
provide valuable information regarding the molecular mechanisms of SMC contraction, they do 
not take into account the effects of force generation in more than one direction or the structural 
considerations involved in the surrounding ECM.   
 In order to obtain specific material properties of the bladder wall, planar biaxial 
mechanical testing may be utilized in the passive and active states that allow for quantification of 
force production biaxially by the SMC (Figure 1-9). Biaxial testing of the bladder wall allows us 
to obtain specific mechanical data describing the stress strain response of the bladder wall under 
more physiological conditions (Fig 1-10). Recently, our laboratory has examined the whole 
organ strain of the passive and inactively filling of bladders (Figure 1-11). We found that bladder 
stretching while filling was anisotropic and stiffer in the circumferential direction. Although the 
bladders in the passive state exhibited less overall compliance, bladders stretched to the same 
degree in both directions yielded similar areal stretches in both states (Parekh submitted).  
However, there were some qualitative differences between the two states were seen early in the 
filling process that were a result of smooth muscle tone.   The results of this study emphasize the 
importance of considering the whole bladder in contributing to its mechanical behavior.  
However with all of the mechanical testing methods, actual contributions of BSMC, passive 
connective tissues, effects of innervation and transport are difficult to separate in these 
approaches.  
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Figure 1-9 . Biaxial testing set up and device 
 
Figure 1-10. Representative stress strain curves from biaxial testing of a normal rat bladder [64]. 
(A) (B)
 
Figure 1-11. A. Example images of a bladder with markers from both cameras before and after filling.  Axes were 
defined for the longitudinal, L, and circumferential, C, directions. B. Higher pressures during filling indicated less 
compliance of the rat bladders in the passive state. Average peak pressure values were 16.7 and 6.4 mm Hg in the 
passive and inactive states, respectively, and were significantly different (p<0.05). Data are presented as the mean 
± standard error (n=5).  The greater variability in the passive data was a result of spontaneous bladder 
contractions throughout the experiment. 
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1.3.2 Ex vivo bladder culture 
Ex vivo organ culture of the bladder provides a means to separate the effects of innervation and 
the tension associated with bladder filling from contractile forces. It also maintains the native 
tissue cell-ECM interaction of the intact organ and allows isolation of the intact organ from 
systemic humoral and neurological influences [65]. Furthermore, organ culture provides an 
alternative to using SCI models where the spinal cord is transected, which are difficult and have 
high morbidity rates for the animals. 
Organ culture of the urinary bladder has been utilized to examine bladder cell 
metabolism, bladder outlet obstruction, and most frequently, bladder cancer. Hardin et al studied 
mitochondrial oxidative substrate selection in porcine bladder smooth muscle strips cultured in 
physiological saline solution up to 4 days [66]. The authors concluded that BSMC have the 
ability to induce lipotoxicity causing dysfunctional detrusor smooth muscle [66]. The mouse 
bladder has also been used ex vivo to study bladder development. Beauboeuf et al examined 
bladder development in fetal mice with ex vivo organ culture of the bladder [67].  Ligation of 
ureters and urethrea prompted more orderly packing of the collagen along luminal edge of the 
developing bladder after 4 days ex vivo culture [67]. Ex vivo culture has also been used as an 
experimental model for the obstructed bladder. Capolicchio et al examined ECM gene response 
in an ex vivo model of rat bladder outlet obstruction [68]. They found that collagen I, III, and XII 
as well as RHAMM gene expression is up regulated under stretch injury. Collagen I and III gene 
up regulation depends on time of distention, not on extent of distention. The effect of a peptide 
that binds in place of the hyaluronic acid receptor, RHAMM, attenuates collagen I, III, and XII  
gene up regulation in a stretched ex vivo rat bladder for 24 hours [68]. Mechanical stretch has 
been shown to alter ECM gene expression as well as alter the release of growth factors and other 
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cytokines. Adam et al showed that mechanical stretch of bladder smooth muscle cells on a flex-
cell device up regulated expression of many genes related to HB-EGF and COX-2 [69]. The 
study also examined PDGF-BB along with mechanical stretch as a stimulator for SMC 
hypertrophy in the isolated cells as well as in an organ culture of a rat bladder at 24 hours [69]. 
These studies proved that ex vivo organ culture may be utilized to examine a pathological 
bladder condition. 
The most frequent use of organ culture of the bladder has been to examine invasive 
bladder carcinoma. Fujiyama et al found that the urokinase system is important for bladder 
cancer invasion through the use of explanted, de-epithelialized bladder sections underneath a 
collagen gel seeded with human bladder cancer cell lines up to 28 days [70]. This system and 
others like it may be used to study the dose effects of therapeutic cancer drugs. Furthermore, 
Estrada et al utilized an ex vivo model of the rat bladder to study the behavior of human 
transitional cell carcinoma (TCC) [65]. The model was a filled rat bladder with the urothelium 
layer removed by digestion in acid. Following digestion, the TCC cells, previously labeled with 
quantum dots, were injected into the bladders. The bladder was grown in cell culture media 
which was changed every other day for up to 20 days [71]. This assay system, termed EViTAS, 
can mimic tumor growth in the host bladder. All of these previous studies exemplify the utility of 
an ex vivo organ culture model of the bladder. While the studies by Capoliccio and Adam 
examined the role of distension of the bladder wall, there currently are not any published reports 
of utilizing a dynamic ex vivo organ culture system of the bladder. 
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1.3.3 Mechanical stimulation of BSMC 
On the whole, BSMCs are poorly understood in their development, contractile properties, ECM 
production, and remodeling within the bladder wall. Previous studies have focused on the organ, 
tissue, or isolated BSMC levels [62].  While organ and tissue studies can provide valuable 
information, they are also limited in that the contributions of BSMC, passive connective tissues, 
innervation, and transport are difficult to separate [62]. In attempts to further understand bladder 
smooth muscle, many have turned to stretching BSMC in culture. It has become well known that 
BSMC exhibit various cellular/molecular-level changes in response to mechanical stimuli such 
as cyclic stretch [72, 73]. These previous studies exposed smooth muscle cells and urothelial 
cells (cultured on flexible membrane) to repetitive mechanical stretch/relax stimuli at various 
frequencies (in the order of 5 – 60 cycles / minute) and magnitudes (in the order of 1% – 25%) 
for hours using commercial or custom devices and examined changes in mRNA and/or protein 
expressions for growth factors, cytoskeletal proteins, extracellular matrix proteins, and integrins 
[69, 72, 74].  In a pilot experiment, it has been shown that mechanical stimulation can also affect 
cellular alignment of BSMC (Figure 1-12). Under uniaxial stretch the BSMC aligned 
perpendicular to the direction of stretch while under equi-biaxial mechanical stretch the BSMC 
showed little to no preferred alignment. These results are further discussed in Appendix A. 
 
 27 
 
 
Figure 1-12. Rhodamine-phalloidin of staining of BSMC under uniaxial stretch for 48 hours (A), in static culture 
(B), and under equibiaxial stretch for 48 hours (C). The white arrows in (A and C) show the direction of strain. 
BSMC appear to line up perpendicularly to the direction of strain in A. In static culture, the BSMC have no 
apparent preferred orientation (B). BSMC show a slight preferred direction diagonally under equi-biaxial stretch 
(C) 
 
While information gained from cell stretch experiments is highly valuable at the cellular 
level, it does not provide an environment wherein the BSMC proliferate and organize their ECM 
under the mechanical stimulation. Furthermore, existing devices such as the Flexercell® for 
mechanical stimulation of cells in a 2-D environment produce stretch that is heterogeneous, 
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which cannot be reliably controlled in the biaxial strain state [62, 75]. BSMC studies are thus 
limited in that critical functional connections to the surrounding ECM and BSMCs are severed, 
and moreover are not subjected to a sufficiently controlled mechanical environment. An in vitro 
model, such as those in the present study, may provide such a platform to perform novel studies 
that examine intrinsic bladder smooth muscle cell physiology and cell-cell and cell-matrix 
interactions.  
1.4 TISSUE ENGINEERING THE BLADDER WALL 
1.4.1 Need for bladder wall replacement 
Bladder wall tissue replacement could be a useful treatment of pathologies present in cancer, 
chronic inflammation, diabetes, or neurogenic disorders [76]. Many neurologically impaired 
patients develop refractory neurogenic detrusor overactivity that are resistant to anticholinergic 
drugs or medication.  Although sacral nerve neuromodulation and bladder botulinum toxin 
injection are being investigated for the treatment of refractory detrusor overactivity [77], the 
“gold standard” therapy for neuropathic bladders as well as those affected by bladder cancer and 
chronic inflammation is enterocystoplasty.  Addition of a segment of intestine to the bladder is a 
major operation with long term risks including not only bladder rupture and bowel obstruction 
but also new cancer formation [78, 79].  Tissue engineering of the bladder wall is a promising 
method to significantly improve upon on enterocystoplasty. 
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1.4.2 Bladder development 
In order to tissue engineer the bladder wall, it is helpful to understand bladder wall development. 
In the case of the urinary bladder, epithelial-mesenchymal interactions are crucial to 
development. Embryologically, the urinary bladder is derived from undifferentiated mesenchyme 
and endoderm of the urogenital sinus and allantois as a tubular organ following subdivision of 
the cloaca by the urorectal spectrum. During development, the undifferentiated mesenchyme 
differentiates into bladder smooth muscle [80]. Similarly, bladder epithelial cells begin as 
undifferentiated, which in time, form urothelium characterized by expression of cytokeratins and 
uroplakins [81]. It has been shown previously that urothelial and smooth muscle cells undergo 
differentiation in an orderly fashion defined by smooth muscle and cytokeratin markers [81].  
Given the orderly differentiation of the bladder layers, the mesenchymal-epithelial interactions 
likely play a role in development of the epithelium, lamina propria, and smooth muscle 
development. In order to assess these cell-cell interactions in bladder development, a study was 
performed by Baskin et al in 1996 where undifferentiated bladder mesenchyme was isolated and 
grown alone or in combination with bladder epithelium [81]. Baskin and his colleagues found 
that in vitro as well as in vivo, tissue recombinants showed evidence of smooth muscle 
differentiation. Without the urothelium, bladder smooth muscle does not develop normally if at 
all [82]. These studies confirm that signaling from the epithelium appears to be required for 
smooth muscle development [83].  
 The mechanism(s) by which the epithelium signals the mesenchyme in bladder 
development are not fully understood. It has been determined that peptide growth factors such as 
keratinocyte growth factor (KGF), TGF alpha and TGF beta are regulated during bladder 
development [84]. Additionally, in a tissue recombination experiment wherein 14-day bladder 
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mesenchyme was combined with rat epithelium from several different tissues, it was found that 
epithelium induces bladder mesenchyme to differentiate into smooth muscle regardless of the 
source of epithelium [85]. More recent studies shed light on new experimental techniques to 
determine the molecular mechanisms behind mesenchymal-epithelial interactions in the bladder. 
In the bladder, as in many other developing organs, mechanical cues such as cell stretch and 
pressure influence the epithelium to release growth factors such as FGF-7 and VEGF that can act 
as potential mitogens [86].  Transgenic mouse models have also been used to examine urinary 
bladder development. The use of transgenic mice allows manipulation of the genetic make-up, 
which simplifies the task of determining the specific effect of a variable in the complex system 
of mesenchymal-epithelial interactions [87]. Going one step further, green fluorescent protein 
may be used in transgenic mice in order to better sort and characterize smooth muscle cells as 
they differentiate from the mesenchyme. In 2004, Szusik et al generated six lines of transgenic 
mice to express the enhanced green fluorescent protein (EGFP) reporter gene under the control 
of a smooth muscle gamma actin protein fragment. The EGFP tagged bladder smooth muscle 
cells were easily isolated, making it more feasible to examine the genetic programs controlling 
development and differentiation of bladder SMC [88]. These techniques may also be used on the 
adult bladder to determine the importance of mesenchymal-epithelial interactions in tissue 
regeneration. 
1.4.3 Tissue engineering methodology 
As stated in section 1.4.1, there is a substantial clinical need for new bladder wall replacement 
tissues. While it is apparent that mesenchymal- epithelial interactions are important in bladder 
wall development, they are also important in maintenance of functional bladder wall in the adult. 
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Mesenchymal-epithelial interactions are important in maintaining bladder homeostasis in 
response to injury [84]. The bladder may be severely affected by disease entities including the 
following: neruogenic bladder dysfunction related to spinal cord injury, bladder dysfunction 
related to urethral obstruction, bladder exstrophy, interstitial cystitis, or bladder cancer. In terms 
of bladder remodeling, it has known for some time that the urothelium of the bladder turn over at 
a slow rate, about once a year [89]. However, the regenerative capacity of urothelium is known 
to occur at an incredible rate, during the first 48 hours after injury such as bladder outlet 
obstruction [87]. Great knowledge can be obtained through understanding mesenchymal-
epithelial interactions in the regenerating bladder. This knowledge will aid in the understanding 
of organogenesis of the bladder and vice versa. 
Experimental models for studying bladder regeneration arise from the diseased state of 
the bladder. These models specifically come from bladder cancer and bladder augmentation. 
Mesenchymal-epithelial interactions have been examined in many types of cancer due to the fact 
that epithelial morphology and function are under stromal control in the embryo and adult. In 
1977, some of the first evidence supporting the theory that carcinogenic agents elicit non-
neoplastic effects in the stroma, which in turn mediate neoplastic development in the epithelium, 
was found in bladder epithelia co cultured with carcinogenic bladder stroma; the epithelia 
developed cancerous cells [90].  Further evidence was provided by Pritchett et al in 1989, where 
epithelial cells from a highly invasive cancerous bladder invaded fibroblast layers in the presence 
of stromal cells [91].  More recent studies have moved away from bladder carcinoma and focus 
on the changes in mesenchymal-epithelial interactions between prostate epithelium and stroma 
[92]. However, a lot can be learned about the mechanisms behind cancer resulting from disrupted 
mesenchymal-epithelial interactions that may be applied to a variety of tissues. 
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 As stated before, reciprocal cellular signaling between the urothelial and stromal 
components are required for development and presumably used to maintain the adult tissue. The 
interactions between the urothelium and the stroma are disrupted when there is a need for 
bladder augmentation [83].  
 Current strategies for bladder augmentation are based on the use of sheets of tissue 
derived from the intestinal tract. Implanting a piece of such tissue into the bladder disrupts the 
interaction between the urothelium and smooth muscle cells and may cause adenocarcinoma in 
some patients [83]. In the majority of patients, however, bladder augmentation provides the 
bladder with increased capacity and aids in voluntary voiding. Replacing the bladder with 
gastrointestinal segments demonstrates the plasticity of the urothelial phenotype. Li et al 
performed tissue recombination experiments by combining a 14-day embryonic rat and mouse 
rectal mesenchyme with urothelium from embryonic and adult rats or mice [93]. They found that 
the phenotype of both mouse and rat urothelium transdifferentiated into glandular epithelium 
demonstrating that plasticity of urothelium is a result of mesenchymal/stromal stimulation. 
Another study demonstrated in vitro the importance of urothelial-smooth muscle interactions in a 
tissue engineering setting. Bladder acellular matrix was seeded with urothelial and smooth 
muscle cells alone and in combination, but smooth muscle cell penetration was found only in the 
co-culture condition [94]. This study further emphasizes the reciprocal need for mesenchymal-
interactions in tissue growth, yet the mechanisms behind the cellular signaling are still not fully 
understood. 
 In general, an ideal bladder wall replacement should consist of [95]: 
1) A normal urothelium lining to prevent abnormal urine resorption 
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2) A substantial, well organized contractile smooth muscle layer(s) to facilitate bladder 
emptying.  
 
Figure 1-13 . Bladder augmentation schematic. [96] 
 The field of tissue engineering (TE) has made significant advances toward improving 
treatments for bladder wall augmentation. TE of bladder smooth muscle includes a variety of 
approaches. Synthetic materials are strong, can be fabricated to degrade following implantation 
at predetermined rates, and can be designed to mimic the material properties of the native tissue 
they are designed to replace [97]. However, these materials have a higher occurrence of 
infection, erosion, and urethral fistula formation [98]. There has been significant initial success 
in engineering a neo-bladder utilizing a polymeric scaffold seeded with autologous urothelial and 
smooth muscle cells (Shown in Figure 1-14) for replacement in children with myleomengcyle (a 
congenital abnormality causing little to no bladder capacity) [99]. This pioneering study 
achieved its primary goal, to increase bladder capacity and thus decrease pressure build up in the 
bladder that would eventually lead to kidney damage. However, these neo-bladders were grossly 
disorganized and did not have the ability for a coordinated contraction of the bladder smooth 
muscle bundles.   
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Figure 1-14. Engineered neo-bladder. [99] 
  Xenographic ECM grafts have also been shown to be useful in reconstructing parts of the 
lower urinary tract [100], though their use as a bladder wall substitute has lead to bladder wall 
stiffness, and incomplete, disorganized muscle regeneration [101]. Porcine small intestinal 
submucosa (SIS) is one such scaffold composed mainly of collagen type-I.  SIS has shown to be 
resorbable [102] and support vascularization in vivo [103]. Many preliminary studies have shown 
that SIS is useful for several types of urologic surgery applications where reinforcement of native 
structure or new tissue is needed [104, 105]. It has been pointed out, however, that SIS initially 
exhibits higher mechanical stiffness than the native bladder and leads to incomplete, 
disorganized muscle regeneration in the urinary bladder [106]. Prior studies have suggested that 
seeding SIS with autologous cells may be advantageous in regenerating functional and 
mechanically sound tissue replacements.  Autologous skeletal muscle cells suspended in a 
collagen gel seeded onto SIS showed higher mechanical tensile strength than unseeded SIS when 
implanted into the abdominal muscles of Lewis rats [107]. In addition, using a de-cellularized 
bladder matrix seeded with canine autologous urothelial and bladder smooth muscle cells for 
bladder augmentation resulted in an increase in bladder capacity [108] and a more complete 
retention of implanted diameter [109] compared to unseeded matrix. These studies provide 
evidence that a tissue engineering approach, utilizing autologous cells and a 3-D, biological 
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scaffold, toward urologic tract repair and replacement may provide better long-term successes. 
Figure 1-15 depicts a piece of SIS. 
 
 
Figure 1-15. Small intestinal submucosa. www.medscape.com 
 
 Cell seeded scaffold approaches have focused on BSMC, since urothelium have a great 
regenerative capacity [110], have had better results in decreasing the contracture of the graft and 
increasing host cell integration [111]. However, there still exists the risk for inflammation and 
disorganized muscle regeneration as well as issues with cell survival post implantation. One 
possible cause behind the shortcomings of current techniques is that most existing TE 
approaches to bladder wall repair are not conditioned in vitro due to the difficulty in mimicking 
the in vivo environment with a scaffold.  
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1.5 MOTIVATION AND AIMS OF PRESENT STUDY  
Multiple bladder wall pathologies, such as overactive bladder, bladder outlet obstruction, SCI 
and related neurogenic disorders, and diabetes result in tissue remodeling marked by 
hypertrophic BSMC and altered extra-cellular matrix components.  This remodeling results in 
changes in bladder wall biomechanical properties leading to altered bladder function. Our 
previous studies have revealed that during the initial areflexic phase of SCI the bladder wall 
undergoes profound remodeling that appears to be a compensatory mechanism for the increased 
wall stretch resulting from over-distension [112, 113]. Remodeling in the bladder wall results in 
changes in biomechanics and ultimately the ability of the organ to normally fill and void [55]. 
The stimuli and precise mechanisms that are responsible for bladder remodeling in SCI remain 
unknown. In order to improve our understanding of post-SCI remodeling events that will lead to 
improved treatment bladder disorders, one must first have an understanding of the primary 
stimulus that triggers remodeling events in the bladder. Specifically, it is hypothesized that 
BSMC respond to altered strain histories with tissue remodeling marked by changes in 
ECM composition resulting from a shift in BSMC phenotype. As a first step, the proposed 
study assessed remodeling events specific to the areflexic phase following SCI.  Our rationale is 
that this is the first phase of bladder remodeling and is likely caused by an abnormal strain 
history differing from the normal filling and voiding patterns of the healthy bladder wall. Based 
upon the aforementioned research areas, the aims of the present study were as follows with a 
depiction of the aims in a flowchart in Figure 1-16: 
 
Specific Aim 1: Determine the effect of strain history on ECM remodeling of the ex vivo 
organ cultured bladder. We hypothesized that abnormal strain frequency would promote ECM 
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synthesis. In order to test this hypothesis we utilized female Sprague Dawley rat bladders 
stretched in a strip-biaxial bioreactor at varying strain frequencies. Remodeling was assessed via 
quantification and visualization of collagen and elastin content. The scientific endpoints were to 
establish organ culture as an experimental model to examine strain induced remodeling of the 
bladder wall and to determine the strain history protocol to promote BSMC remodeling of ECM.  
 
Specific Aim 2: Examine the role of TGF-ß1 with and without cyclic stretch on bladder 
smooth muscle remodeling.  
 Aim 2.1: Utilize ex vivo culture model to examine role of TGF-ß1. We hypothesized 
that TGF- ß1 will increase BSMC mediated ECM remodeling in the ex vivo organ culture by 
altering BSMC phenotype. This hypothesis was tested using the same organ culture system as 
described in Aim 1. Phenotype of the BSMC within the cultured bladders was assessed by 
utilizing immunohistochemistry to stain the sections for contractile and synthetic smooth muscle 
cell markers. The scientific endpoint of this sub-aim was to assess the role of TGF-ß1 with and 
without strip biaxial stretch on BSMC phenotype, ECM synthesis, and mechanical properties and 
compare these outcome measures to established data on the SCI rat bladder. 
 Aim 2.2: Further examine role of TGF-ß1 in cell remodeling with collagen gels. We 
hypothesized that TGF- ß1 will increase BSMC mediated ECM remodeling of collagen gels. 
This hypothesis was testing using an anchored collagen gel model. We measured contractility of 
the gels as well as organization of the collagen within the gels. The scientific endpoint of this 
aim was to quantitatively and qualitatively assess the impact of exogenously added TGF- ß1 on 
BSMC remodeling ability. 
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Specific Aim 3: Engineer a cell-ECM construct to further examine the effect of strain on 
BSMC remodeling with future applicability in tissue engineering the bladder wall. We 
hypothesized that: 
1. Cytokines VEGF and FGF-2 will promote cellular penetration into SIS. 
2. Non-physiologic strain histories will promote a similar response in the cell-ECM 
construct as demonstrated in organ culture. 
These hypotheses were tested utilizing BSMC, the cytokines VEGF and FGF-2, and the 
tension bioreactor described in Aim 1. Two stretch frequencies were examined, 0.5 Hz and 0.1 
Hz with strain up to 15%. The scientific endpoints of this aim were to ascertain a method to 
rapidly promote penetration of the BSMC into SIS and to promote ECM remodeling within the 
SIS construct with the use of cyclic mechanical stimulation. 
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Information learned previously from SCI bladder model: 
- Strain may be key factor in ECM remodeling
- TGF-ß1 is up-regulated in SCI
Examine role of strain history on 
ECM remodeling in the ex vivo 
bladder.
Hypothesis: abnormal strain frequency 
promotes ECM synthesis
• Establish organ culture as an 
experimental model to examine strain 
induced remodeling of the bladder 
wall.
• Determine protocol to promote 
BSMC remodeling of ECM.
Utilize ex vivo culture model to 
examine role of TGF-ß1.
Hypothesis: TGF- ß1 will increase 
BSMC mediated ECM remodeling in 
the ex vivo organ culture by altering 
BSMC phenotype 
Assess role of TGF-ß1 with and 
without strip biaxial stretch on:
• BSMC phenotype
• ECM synthesis
• Mechanical properties
Engineer a cell-ECM construct to 
further examine the effect of strain 
on BSMC remodeling with future 
applicability in tissue engineering 
the bladder wall.
Hypothesis: 
1. Cytokines VEGF and FGF-2 will 
promote cellular penetration into SIS.
2. Non-physiologic strain histories will 
promote a similar response in the cell-
ECM construct as demonstrated in 
organ culture.
• Utilize growth factors to promote 
penetration of BSMC.
• Expose BSMC/SIS to strain 
frequencies of 0.1 Hz and 0.5 Hz and 
examine effects on ECM synthesis 
and turnover.
Aim 1 Aim 2.1
Aim 3
Further examine role of TGF-ß1 in 
cell remodeling with collagen gels.
Hypothesis: TGF- ß1 will increase 
BSMC mediated ECM remodeling of 
collagen gels .
Utilize collagen gel model to examine 
role of TGF-ß1 on BSMC contractility 
and gel organization
Aim 2.2
 
 
Figure 1-16.  Flowchart of specific aims based upon previous studies of the SCI affected bladder. These aims sought 
to test the overall hypothesis that BSMC respond to altered strain histories with tissue remodeling marked by 
changes in ECM composition resulting from a shift in BSMC phenotype. 
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2.0  THE EFFECTS OF TISSUE LEVEL STRETCH ON URINARY BLADDER 
WALL EXTRACELLULAR MATRIX REMODELING 
2.1  INTRODUCTION 
Urinary bladder wall (UBW) pathologies resulting from bladder outlet obstruction diabetes 
mellitus, spinal cord injury and related neurogenic disorders, commonly lead to substantial tissue 
remodeling marked by hypertrophic BSMC and altered ECM components.  This remodeling 
results in changes in bladder biomechanical and structural properties leading to altered bladder 
function.  In vivo studies of bladder outlet obstruction have demonstrated increases in bladder 
vascularization [114] and weight [115], as well as alterations in smooth muscle contractility 
[116]. In the rat streptozotocin induced diabetes model, increases in bladder capacity, cross 
sectional area, and hypertrophic smooth muscle have been identified as indicators of remodeling 
[117]. The UBW also undergoes remodeling with rapid changes in ECM composition and 
smooth muscle hypertrophy following spinal cord injury [112].  Previous studies have revealed 
that during the initial areflexic phase of spinal cord injury the bladder undergoes profound 
remodeling that appears to be a compensatory mechanism for the increased wall stretch resulting 
from over-distension [112, 113]. Remodeling in the UBW results in biomechanical changes and 
ultimately the ability of the organ to normally fill and void [55].  
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The normal urinary bladder is composed of approximately 70% smooth muscle with the 
remaining 30% being ECM proteins, predominantly collagen types I and III with a loose network 
of elastin fibers [117, 118].  The majority of the elastin found in the bladder is in the vasculature, 
with small additional amounts found surrounding individual bladder smooth muscle cells [119], 
within the connective tissue connecting smooth muscle bundles [120], and in the urothelium and 
lamina propria [121]. While in most soft tissues a certain amount of turnover of the ECM 
constituents is expected, elastin is generally assumed to be metabolically stable with negligible 
turnover rates [122].  
In the aforementioned bladder pathologies, the balance of smooth muscle and ECM 
components is altered leading to either a highly compliant and over distended bladder (as seen in 
early stages of spinal cord injury [54] or diabetes [123], or a non-compliant, fibrotic bladder (as 
seen in late stages of spinal cord injury [64] or in bladder outlet obstruction [124]). These studies 
indicate that maintenance of the ratios of ECM and smooth muscle is essential to normal bladder 
function. Thus, understanding the remodeling process in the diseased state is crucial in treatment 
and developing methods to restore the bladder function. 
Although much information can be obtained by studying bladder tissue remodeling in 
vivo, the multiple effects of innervation, immune responses, and heterogeneous wall deformation 
and stress associated with filling and voiding are difficult to separate.  Ex vivo organ culture 
models have been established to examine UBW development [67], cancer [70, 71, 125], 
metabolism [66], and bladder outlet obstruction [68, 69].  Capolicchio et al. examined ECM gene 
response in an ex vivo model of rat bladder outlet obstruction and found that collagen I, III, and 
XII gene expression is up-regulated under stretch injury [68]. In an additional organ culture 
study using the same rat bladder outlet obstruction model, mechanical stretch along with PDGF-
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BB were stimulators of SMC hypertrophy after 24 hours of distension [69]. These studies 
demonstrate that an ex vivo model of the UBW is feasible and useful in examining a strain-
induced remodeling.   
However, the modes of mechanical stimulation that are responsible for bladder 
remodeling in response to strain remain unknown. In order to more firmly establish our 
understanding of UBW remodeling events, it is necessary to have an understanding of the 
mechanisms that trigger these events. In particular, while it is intuitive that mechanical forces 
and deformations likely drive the remodeling processes, definitive studies have yet to be 
performed for the UBW. Thus, while the primary function of the bladder is mechanical, our 
understanding of the remodeling process and the role of mechanical stimulatory factors for the 
bladder remains surprisingly limited.  
The objective of the present study was to accomplish the endpoints of Specific Aim 1: 
determine the effect of strain history on ECM remodeling of the ex vivo organ cultured bladder. 
Which were to establish organ culture as an experimental model to examine strain induced 
remodeling of the bladder wall and to determine the strain history protocol to promote BSMC 
remodeling of ECM. Thus, this study determined the effects of varied, continuously cycled strain 
histories on ECM production in the ex vivo rat bladder as a first step toward full understanding 
of the remodeling process. In particular, we speculate that strain history plays a pivotal role in 
determining the responses of the UBW. An ex-vivo organ culture system was utilized to remove 
the potentially confounding effects of innervation and humoral factors from strictly mechanical 
strain effects. Resulting changes in ECM components were quantified. 
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2.2 PROTOCOLS 
2.2.1 Ex vivo organ culture 
Bladders were extracted from female Sprague-Dawley rats (150-300 g) following euthanasia 
with CO2 . Bladders were opened and strips 9- 10 mm in the circumferential direction x 12-14 
mm in the longitudinal direction were excised. Strips were attached on the longitudinal ends with 
custom-made tissue grip springs. Samples were then mounted in a custom-made tension 
bioreactor (Fig 1D) and stretched in the longitudinal direction for 7 or 14 days under sterile 
conditions in RPMI-1640 (Invitrogen) media supplemented with 10% FBS (Invitrogen) and 1% 
PenStrep (Invitrogen) at 37 degrees and 5% CO2. Bladder samples were stretched to 20% under 
either 0.5 Hz,  “1 hour” (stretched to 20% over an hour then released over 10 seconds), or “8 
hour” (stretched to 20% over 1 hour, held for 7 hours, then released over 10 seconds). Freshly 
excised bladder strips (referred to as “Native”) and free-floating, statically cultured bladder strips 
(referred to as “Static”) served as controls. The 0.5 Hz group was chosen based upon previous 
studies wherein BSMC were stretched on distensible membranes [126]. The 1 hour group was 
chosen to mimic rat bladder voiding, and the 8 hour group was chosen to mimic SCI bladders 
that were expressed 3-4 times daily. See Table 2-1 and Figure 2-1 for stretch protocol 
descriptions and waveforms.  
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Figure 2-1. Sample waveforms for (A) two cycles of “1 hour cycle”, (B)  two cycles of “8 hour cycle” and (C) 
several cycles of “0.5 Hz cycle” in the ex vivo rat bladder strips. (D) A photograph of the tension bioreactor. 
 
 
 
Table 2-1. Stretch Protocols 
Protocol 
name 
Description 
Native Freshly excised tissue 
Static Statically cultured tissue 
0.5 Hz Cyclically stretched to 20% from its initial length at 0.5Hz, for 7 or 
14 days  
1 hr Stretched to 20% from its initial length over 1 hour then released 
over 10 seconds, repeated for  7 or 14 days 
8 hr Stretched to 20% from its initial length over 1 hour, held for 7 hours, 
then released over 10 seconds, repeated for  7 or 14 days 
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2.2.2 Tissue strains experienced in the tension bioreactor system 
 In order to determine the strains experienced by the ex vivo bladder strips in the tension 
bioreactor system, a custom designed strip biaxial testing device was utilized as described 
previously [127]. Briefly, the testing apparatus consisted of a small bath secured to a computer 
controlled translation stage to which one end of the specimen could be mounted via a bar 
attached to the moving bath and the other end of the specimen mounted via a fixed bar. The bath 
was then moved with a linear actuator such that the bladder strip was stretched to 20% from its 
initial length. Tissue strains were measured by tracking 4 markers placed in a square on the 
middle of the bladder specimen. Additionally, to determine any plastic deformation that occurred 
over the length of time in culture, measurements were taken by hand of the length and width of 
each sample before and after culture.  
 
2.2.3 Collagen and elastin assessment 
Collagen and elastin concentrations were determined based on techniques adapted from Brown et 
al [128], which have previously been used to quantify ECM synthesis of ovine vascular smooth 
muscle cells under cyclic mechanical flexure [129]. Soluble collagen was extracted from tissue 
samples using a solution of 0.5 M acetic acid (Sigma) and 1 mg/mL Pepsin A (Sigma). Each 
sample was placed in a microcentrifuge tube and incubated in 1 ml of extraction solution 
overnight (~16 h) on a rocker table operating inside a refrigerator at 2–8°C.  In order to 
determine the amounts of highly cross-linked collagen in the tissue samples, samples were 
denatured in a pepsin/acetic acid solution at 80 °C for 1.5 hours. Following denaturation, 
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samples consisted of solubilized collagen which was measured separately from the pepsin/acetic 
acid digested collagen.  Elastin was extracted using a hot oxalic acid treatment. The supernates 
from the oxalic acid treatments were loaded onto Centricon RC/YM-3 centrifugal filter units 
(Millipore, Bedford, MA) and centrifuged at 3000g for an additional hour. The concentrate was 
then be re-suspended in cold (<5°C) Elastin Precipitating Reagent (UK Biocolor). Soluble 
collagen from the collected media samples at days 2, 4, 7, 9, 11, and 14 was precipitated with 4 
M NaCl. Fresh media was used as the control. Following the extraction steps, the collagen and 
elastin extracts were assayed according to the guidelines provided with the Sircol™ and Fastin™ 
assay kits, respectively (UK Biocolor).  
2.2.4 Matrix metalloproteinase (MMP) activity 
Since the pepsin soluble collagen found in the tissue may be either newly formed collagen or 
degraded collagen, the culture media was assayed for both collagen and bulk matrix 
metalloproteinase activity. MMP activity was assayed from the conditioned media at days 2, 4, 7, 
9, 11, and 14 utilizing a similar method to Aitken et al 2006 [130]. Net activity was assayed 
using the EnzCheck collagenase/gelatinase assay kit (Invitrogen). DQ-gelatin fluorescein 
conjugate (0.1 mg/mL) was incubated in Tris buffer (50 mmol/L) with conditioned media for 2 
hours. The MMPs then released the quenched activity of the FITC from the FITC-gelatin. The 
released FITC was measured on a fluorescent microplate reader at 495 nm absorption and 525 
nm excitation. Collagenase produced in Clostridium histolyticum provided in the kit was used as 
a positive control. Negative controls were performed with 20 µmol/L of 1,10-phenanthroline to 
inhibit the MMP activity. Background from unconditioned media was subtracted from all 
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samples. Data are reported as a summed total of activity from each day media was changed (2, 4, 
and 7 days for 7 day groups and from 2, 4, 7, 9, 11, and 14 days for 14 day groups). 
2.2.5 Histological assessment  
 Following 7 or 14 days in culture, bladder samples were fixed in 10 % neutral buffered formalin 
overnight and transferred to Hank’s Buffered Saline Solution (HBSS, Invitrogen) for storage. 
Once all samples were collected, they were embedded in paraffin, cross-sectioned, and stained 
with Elastic Trichrome. Stained specimens were imaged at 400x. Additionally, 
immunohistochemistry was performed on 3 representative sections from each sample group. 
Following paraffin embedding and sectioning, slides were deparaffinized and antigen retrieval 
was performed using a sodium citrate buffer (Sigma).  Samples were then washed 3x in Tris 
Buffered Saline (TBS, Sigma) and blocked with 0.3% BSA in TBS for 1 hour. Then, samples 
were incubated with an anti-elastin primary rabbit polyclonal antibody (1:400, Abcam Inc.) for 1 
hour at room temperature. Following the primary antibody incubation, samples were incubated 
for 1 hour in FITC labeled goat polyclonal anti-rabbit IgG-H&L (1:400, Abcam Inc). Samples 
were thoroughly rinsed in TBS and incubated in 300 nM 4´,6-diamidino-2-phenylindole dilactate 
(DAPI, Invitrogen) for 10 minutes. Samples were rinsed in TBS and imaged on a Leica DMRB 
fluorescence microscope. Negative controls for elastin antibody staining were a primary antibody 
delete, and positive controls were the blood vessels in the tissue. 
 
 48 
2.2.6 Statistical analysis 
 All numerical data are presented as mean +/- s.e.m. Statistical analyses of these data were 
performed using SigmaStat 3.0 software package (Chicago, Il).  A one-way analysis of variance 
was used on all samples followed by a Tukey test for pair-wise comparisons. Following these 
tests, p-values of less than or equal to 0.05 were considered significant. 
2.3 RESULTS 
2.3.1 Realized tissue deformations 
Analysis of the strains experienced under the strip biaxial organ culture revealed that the bladder 
strips underwent nearly pure strip biaxial stretch in the center portion of the sample. Stretch 
ratios in the longitudinal direction were measured to be 1.196 +/- 0.007 while the entire strip was 
stretched to 1.20 from its initial length. Stretch ratios in the circumferential direction were 1.040 
+/-  0.014, with negligible shear observed.  Measurement of the bladder strips following organ 
culture showed that some permanent set occurs affecting both the longitudinal and 
circumferential directions. The permanent set occurring in the longitudinal direction of the 3 
stretched groups (0.5 Hz, 1 hour, and 8 hour) increased the length by 1.45 +/- 0.65 mm resulting 
in an average stretch ratio between 1.17 and 1.18 instead of the original 1.20. There also was a 
shortening in the circumferential direction by 2.11 +/- 0.70 mm. In the static culture group, 
dimensions of the bladder strips decreased by 1.33 +/- 0.57 mm  and 1.66 +/- 0.54 mm in the 
longitudinal and circumferential directions, respectively.   This shortening was most likely 
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resultant from the unrestrained bladder strip curving back to its native shape of the UBW.    
Overall, the experimental system was able to subject the UBW tissue strips to a predictable and 
consistent strain pattern, with small effects of tissue attachment and permanent set. 
2.3.2 Collagen remodeling in the tissue  
Indications of UBW remodeling were seen in the dynamic organ culture conditions evidenced by 
the collagen assays. A significantly larger amount of pepsin-soluble collagen (non-fibrillar 
collagen) was detected in the native tissue (actual value 2.510 +/- 0.151 mg) compared to the 0.5 
Hz and 1 hr groups at 7 days and the 1 hr and 8hr groups at 14 days (Fig. 2-2A).   Additionally, 
there was a significantly greater amount (p=0.017) of soluble collagen found in the 0.5 Hz group 
at 14 days compared to the same group at 7 days. Pepsin insoluble collagen (fibrillar collagen) 
concentration was not statistically different (p=0.256) among any of the groups following 7 days 
in culture (Fig 2-2B).  The actual value of the insoluble collagen in the native rat bladder was 
found to be 30.784 +/- 3.214 mg.  In contrast to the 7 day results, after 14 days in culture there 
was a significant increase in pepsin insoluble collagen (p=0.033) in the 1 hr group compared to 
the amount found at the 7 day time point (Fig 2-2B).  
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Figure 2-2. Total collagen concentration (pepsin insoluble and soluble) of cultured bladder strips following 7 and 
14 days in culture. (A) Pepsin soluble collagen at 7 and 14 days. The 0.5 Hz and 1 hr groups are significantly 
different p<0.01 than all other groups. The Native group is significantly higher than the 0.5 Hz and 1 hr groups at 7 
days and the 1 hr and 8 hr groups at 14 days * p<0.05. (B) Pepsin insoluble collagen at 7 and 14 days. There were 
no statistically significant differences in insoluble collagen between the groups except for between the 7 and 14 day 
time points in the 1 hr group (p=0.033). All data are presented as mean +/- sem with n=5 or 6 per group. 
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2.3.3 Collagen turnover 
These assay results were summed from each day of collection. After 7 and 14 days in culture, the 
soluble collagen found in the media of the 0.5 Hz group was nearly 20 fold higher than that of 
any other group (Fig 2-3A).  Similarly, at 14 days in culture, the MMP activity of the 0.5 Hz 
group was found to be significantly greater (p<0.05) than that of any other group (Fig 2-3A). 
However, in the 8 hr group, a significant difference was observed (p=0.050) between the 7 and 
14 day groups (Fig 2-3A).  
2.3.4 Elastogenesis 
 Elastin assays along with histology and immunohistochemistry revealed that elastogenesis 
occurred. Histological analysis (Fig 2-4) showed that bladder strips in the organ culture system 
remain viable and structurally intact for up to 7 days in culture. Smooth muscle bundles in 
circumferential and longitudinal layers surrounded by collagen were visible in all samples. 
Samples exposed to stretch appeared to be thinner than the fresh and statically cultured samples 
in histological sections. A large amount of elastin fibers, (Fig 2-4E, arrows), was observed in the 
0.5 Hz group that could not be found in any other groups. Furthermore, immunohistochemical 
staining with the antibody to elastin showed large amounts of positive staining in the 0.5 Hz 
group (Fig 2-5B) while the only positive staining for elastin in all other groups was found only in 
the blood vessels (Fig 2-5 A).  
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Figure 2-3. Soluble collagen and MMP activity found in the culture media (A) 7 and 14 day soluble collagen found 
in the media. Significantly more soluble collagen was found in the 0.5 Hz group media than in all other groups, ^* 
p<0.05. The soluble collagen in the media from 8 hour group at 14 days was significantly greater than the soluble 
collagen from the 8 hour group at 7 days, p=0.050. (B) 7 and 14 day MMP activity found in the media. Significantly 
more MMP activity was found in the 0.5 Hz group media at 14 days than in all other groups, *p<0.05. All data are 
presented as mean +/- sem with n=4 for 7 day groups and n=5 or 6 for 14 day groups. 
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Figure 2-4. Elastic trichrome staining of cross sections of (A) fresh tissue, (B) 7 day statically cultured tissue, (C) 7 
day 1 hr cycle, (D) 7 day 8 hr cycle, (E) 7 day 0.5 Hz cycle, (F) portion of 7 day 0.5 Hz magnified to display the 
elastin. Images are reduced from 400x. Red arrows in (E) indicate areas of elastin formation. Blue represents 
collagen, black represents elastin, purple represents cell nuclei, and red represents cytoplasm. 
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Figure 2-5. Immunohistochemistry with antibody to elastin and DAPI nuculei staining (blue). (A) Overlayed image 
of static culture specimen, note elastin (green) is only seen around blood vessels (arrows). (B) Overlayed image of 
0.5 Hz group at 7 days, note the large portion of fibrilar elasin (green). 
 
Quantitatively, after 7 days in culture, elastin in the 0.5 Hz group was 6 fold greater than 
in the native tissue (actual value native tissue: 239.267 +/- 34.584 µg) (Fig 2-6).  There was no 
change in elastin composition between the native tissue and the static, 1 hr and 8 hr groups (Fig 
2-6). A similar trend was seen at the 14 day time point. Again, there was a significantly greater 
amount of elastin found in the tissues stretched at the 0.5 Hz cycle compared to all other groups 
(Fig 2-6). This up-regulation of elastin in the cyclic group is indicative of elastogenesis and 
confirmed the results found by histology and immunohistochemistry. 
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 Figure 2-6. Elastin concentration of bladder samples following 7 and 14 days in culture. Data are 
presented as mean +/- sem with n=5 or 6 for each group. The 0.5 Hz group at both 7 and 14 days was significantly 
greater,*p<0.001, compared to all other groups. The 1 hour group at 14 days was significantly greater, +p<0.05, 
compared to native tissue.  
 
2.4  DISCUSSION 
2.4.1  Bladder wall tissue remodeling 
This is the first study to the authors’ knowledge that examines the UBW in a dynamic ex vivo 
system, which demonstrated significant ECM remodeling, and in particular profound fibrillar 
elastogeneis. While it is known that the bladder wall undergoes profound remodeling resulting 
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from pathologies such as spinal cord injury or obstruction, there have been few studies 
examining the role of strain in the remodeling process. This study has isolated the effect of strain 
on the UBW, and has shown that strain is capable of inducing collagen turnover and biosynthesis 
as well as elastin production and assembly into fibrils after only 7 days in culture.  Furthermore, 
this study has shown that the strain history of the UBW influences the remodeling process 
greatly, with small changes in collagen synthesis under physiological strain histories, and large 
changes in both collagen turnover and elastogenesis under a non-physiological strain history. 
2.4.2 Strain induced alterations in collagen biosynthesis 
The changes in both soluble and insoluble collagen in the tissue indicated that there is collagen 
turnover occurring dependent on the stretch protocol. MMP results from the media are positively 
correlated to the collagen found in the media (R2=0.98 for 7 days and R2=0.75 for 14 days) thus 
indicating that a portion of the soluble collagen that was found in the media may be 
enzymatically degraded collagen. However, since there was nearly a 20 fold increase in the 
media collagen at 0.5 Hz at 7 days compared with only a 4 fold increase in the media MMP 
under the same conditions, it is possible that there may also be newly formed collagen in the 
media or fragmentation of broken-down collagen that has not been entirely degraded by the 
MMPs.  
In a previous study, MMPs have been found to increase in an ex vivo model of bladder 
outlet obstruction after 24 hours of static distension, and bladder smooth muscle cells responded 
to static distension with an increase in ERK-1,2 [130]. These findings contrast the results from 
the present study wherein MMP activity was only increased in the 0.5 Hz group, not in the 8 hr 
cycle, which is more similar to static distension. The present study looked at the cumulative long 
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term effects of stretch in the ex vivo organ; however, even at the 48 hour media collection, the 
MMP values in the 0.5 Hz group were over 2 fold greater than those of any other group (data not 
shown). The reason for the contrast between our results and others may be due to our organ 
culture preparation involving cutting the sample into a strip that may induce a different 
microenvironment than found in the intact bladder.  
 Additionally, the soluble collagen is decreased in the 1 hr group at 7 days, but there was 
a significantly higher amount of insoluble collagen in the same group at 14 days. These results 
indicate that collagen production is occurring over time and a portion of it is likely being 
incorporated into the tissue. Compared to pathological conditions, this increase in collagen 
concentration in the 1 hr group at 14 days is on the same order of magnitude observed in the rat 
bladder following spinal cord injury at 10 weeks (1.24 and 1.68 fold, respectively [64]). 
Moreover, increased amounts of collagen, or fibrosis, is found in the non compliant bladder 
resulting from non-neurogenic pathologies such as the obstructed bladder or radiation therapy 
[47]. In these previous in vivo studies, bladder fibrosis occurred after the pathological condition 
persisted on the order of months. The 1 hour loading condition in the present study gave rise to 
collagen deposition at 14 days, which was not seen at 7 days, thus indicating that for collagen 
remodeling to occur, longer-term loading may be necessary.   
 
2.4.3 Strain induced elastogenesis in the UBW  
The most extensive tissue remodeling seen in the ex vivo bladder strips occurred in the 0.5 Hz 
group. The increase in elastin concentration of the 0.5 Hz group at both 7 and 14 days (5-6 fold 
compared to native tissue) is indicative of elastogenesis occurring in response to this high strain 
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rate.  This increase in elastin concentration is similar to the increase seen in the spinal cord injury 
affected bladder. At 1.5 weeks following spinal cord injury, the rat bladder contained nearly 4 
fold more elastin than in the normal bladder, and at 3 weeks following spinal cord injury, the rat 
bladder contained 5.19 fold more elastin than the normal bladder [64].  
While the Fastin elastin assay measures all forms of elastin (tropoelastin and mature 
elastin), fibrillar elastin was seen in the Elastic Trichrome staining and immunohistochemistry of 
the cross sectioned samples. Patches of elastin were found throughout the tissues in the 0.5 Hz 
group; however, the large fibrillar bundles were located primarily near the lamina propria above 
the detrusor muscle. In pathological conditions, the majority of newly formed elastin is found 
intra- and interfasically in the detrusor muscle [36, 53, 112, 131]. In the organ culture system 
presented in this study, the bladder smooth muscle cells in the detrusor are preserved in the 
RPMI 1640 culture media, while the urothelium are not viable in the system and slough off the 
bladder strip within in the first day of culture as observed with histological sectioning (data not 
shown).  
Based on our present understanding, definitive evidence for the origin of the elastin 
produced is lacking in part due to the third major cell type found in the UBW, the myofibroblast.  
The media used in this system contains the D isomer of valine that should not support fibroblast 
growth [132]; however, histological sectioning of our bladder strips shows these suburothelial 
myofibroblasts in the regions of the lamina propria where the large amounts of fibrillar elastin 
are located.  At present, the bladder myofibroblasts have not been shown to play a role in bladder 
ECM regulation and have been shown to play a role in electrical signal transduction in the 
bladder [3]. Since the bladder smooth muscle cells make up the vast majority of cells in the 
bladder, and it has been shown previously that bladder smooth muscle cells have the capability to 
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produce elastin in the non-compliant bladder [2], it is reasonable to postulate that tropoelastin 
molecules are produced in the detrusor under the non-physiologic stretch frequency of 0.5 Hz. 
Furthermore, the elastin molecules may be assembled into fibrillar elastin in the thick 
collagenous matrix of the lamina propria since elastin molecules produced by smooth muscle 
cells need an ECM in order to be assembled [68].    
A potential explanation for the extensive fibril formation found in the 0.5 Hz group may 
be due to the effects of the high stretch frequency on the binding sites on the elastin proteins.  In 
a previous study by Jesudason et al. [133], cyclic stretch at 0.33 Hz on an elastin rich ECM was 
found to have a protective effect against elastase activity while a much slower frequency of 
~0.08 Hz was found to increase elastase degradation. The authors explained that the binding sites 
on the elastin were protected at the higher stretch frequency while the binding sites were exposed 
at the lower frequency [133]. Therefore, it is plausible that the elastin produced in the tissue at 
0.5 Hz was protected by the high stretch frequency thus allowing it to form what appears to be 
dense fibrillar elastin within the lamina propria.   The 1 and 8 hour groups are stretched at a 
much lower frequency, potentially exposing any newly formed elastin to degradation. However, 
after 14 days in culture, the elastin in the 1 and 8 hour groups is increased compared to the native 
group and the 1 and 8 hour groups at 7 days. It is possible that with prolonged stretch, the cells 
are producing elastin; yet there was no visible fibrillar elastin in the 14 day histology of the 1 and 
8 hour groups. 
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2.4.4 Stretch frequencies 
 
 The 1 hour and 8 hour stretch protocols in this study were chosen based upon 
approximations of in vivo bladder pathologies in the rat model; however, the results do not 
precisely mimic remodeling found in vivo. During normal voiding, bladder tissue is stretched 
between 10-20% multi-axially. In the present system, the bladder strips are stretched strip 
biaxially with strain applied in the longitudinal direction. In the native rat bladder, the bladder is 
stretched multi-directionally during filling; however the most stretch occurs in the longitudinal 
direction (observation during cystometry). It has been shown previously that the majority of the 
bladder smooth muscle bundles are oriented longitudinally in the rat bladder [112]. By stretching 
the bladder to 20% in the longitudinal direction, a contractile response may be elicited, further 
mimicking the native bladder as it stretches for filling and contracts for voiding [4]. Ideally, to 
determine the forces generated by this contractile response in the organ culture system, load cells 
would be used for real time measurement of the bladder strips during stretch. The addition of 
load cells to our bioreactor set up is not trivial; however, this option will be explored in our 
future studies.   
 In diseased states such as spinal cord injury or bladder outlet obstruction, the bladder 
may be over-distended to 25% stretch or more. The rates of voiding also vary greatly between 
normal and diseased states i.e., in the normal rat, the bladder fills over 1-1.5 hours and voids over 
10 s between 18 – 24 times daily, and in the spinal cord injury rat the bladder fills over 1 hour 
but only voids 3-4 times daily [134]. Previous studies of these physiological conditions showed 
remodeling of the bladder, specifically in the spinal cord injury pathology (similar to our 8 hour 
cycle) [35], indicated by alterations in ECM proteins, hypertrophy, and biomechanical 
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properties. However, the non-physiological loading state of 0.5 Hz produced a model most 
closely mimicking UBW remodeling in the disease state. The 0.5 Hz frequency stimulated the 
largest amount of tissue remodeling indicated by the large quantity of elastin produced in the 
tissue and the large quantity of collagen and MMPs released into the culture media. 
2.4.5 Influence of strain history  
The 0.5 Hz frequency in this study was chosen to deliver a non-physiologic strain history to the 
bladder strips based upon information from isolated cell studies on smooth muscle. Smooth 
muscle cells isolated from the bladder have been shown to express up-regulated ECM genes, 
specifically collagen types I and III and fibronectin, under high frequency stretch protocols 
ranging from 0.1-1 Hz.  Stretch frequency ranges have been shown to alter cellular gene 
expression for contractile proteins alpha-smooth muscle actin and calponin as well as collagen 
types I and III [126] [135].  At a stretch frequency of 0.5 Hz, collagen type I was up regulated in 
bladder smooth muscle cells while at a stretch frequency of 0.4 Hz, collagen types I and III along 
with fibronectin were up regulated [126]. There are currently no studies that have examined the 
effect of the 0.5 Hz frequency in bladder smooth muscle cells with regard to elastin production. 
However, under static pressure bladder smooth muscle cells produced a larger amount of elastin 
than cells under atmospheric pressure [136]. Additionally, vascular smooth muscle cells seeded 
on a collagen gel produced elastin when stretched at 0.5 Hz [137]. The aforementioned studies 
suggest that remodeling in the UBW may depend on the frequency of strain; however, future 
studies will also examine the effects of the magnitude of strain in this ex vivo system.  These 
previous studies along with data obtained in the current study indicate the need to examine both 
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physiological and non-physiological stretch frequencies in order to have an understanding of 
bladder function in disease. 
2.4.6 Examining the limits of ex vivo organ culture 
In order to further examine the role of strain on ECM remodeling, two pilot studies were 
performed examining 1) larger strain of 40% and 2) a physiologic fast cyclic stretch frequency of 
0.1 Hz. The physiologic fast cyclic may be considered physiologic because the bladder wall 
undergoes rhythmic contractions 1-5 times a minute. The 0.1 Hz frequency may approximate 
these peristaltic contractions. For the larger strain experiment, 6 bladder strips were prepared as 
described in the protocol section 2. These 6 bladders were stretched for 7 days to 40% stretch at 
0.5 Hz. Following the stretch the same outcome measures were utilized. These experiments 
showed that by stretching at 0.5 Hz to 40 % there was significantly more collagen in the tissue 
compared to the 20% stretch at 0.5 Hz (Figure 2-7). Additionally, stretching to 40% did change 
the amount of elastin in the tissue with a significant increase compared to the native and a 
significant decrease compared to the 20% 0.5 Hz tissue (Figure 2-7). These results indicate that 
ECM composition in the rapidly cycled bladder groups is not only frequency dependent but also 
stretch dependent. 
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 Figure 2-7. A. Soluble collagen following 7 days organ culture. Significance determined by one way ANOVA 
followed by Student Newman Keuls test for multiple comparisons. B. Fold increase over native elastin 
concentration. Data are presented as mean +/- sem, n=5-6 per group. *p<0.001 compared to native. +p<0.001 
compared to native. 
 
2.4.7 Implications for engineered smooth muscle tissues 
In many of the aforementioned urinary bladder pathologies (bladder outlet obstruction, diabetes 
mellitus, and spinal cord injury or related neurogenic disorders) wherein remodeling of the ECM 
occurs, the chronic disease state ultimately leads to the need for bladder replacement.   The field 
of tissue engineering has made significant strides in improving upon traditional methods of 
UBW replacement.  Replacements are usually comprised of autologous cells that have been 
seeded on either a biodegradable polymeric scaffold [138] [139] or xenographic decellularized 
matrix, such as small intestinal submucosa (SIS) [140, 141] or bladder acellular matrix (BAM) 
[100, 142].  The recent findings of an initial clinical study by Atala et al. [99] showed significant 
and exciting success utilizing autologous urothelial and smooth muscle cells on a composite 
matrix implanted into patients with myelomeningocele. The patients’ bladder capacities and 
compliance were increased; however, functionality of the bladder could not be determined.  
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Studies utilizing these methods have shown regenerated urothelium [82], smooth muscle fibers 
and multiple blood vessels [82], in addition to minimizing inflammatory reactions up to 22 
weeks [143]. 
Yet, despite these encouraging results, incomplete and disorganized bladder smooth 
muscle regeneration has been observed 22 weeks post-implantation [143].  Typically, smooth 
muscle cells were observed to aggregate into small, irregular muscle bundles and did not achieve 
the large-scale tissue structures observed in the native bladder [143]. In another study, smooth 
muscle cells were arranged only longitudinally compared to the circumferential and longitudinal 
orientations found in the native UBW [82].   The above cited studies underscore that in-vivo 
remodeling by itself cannot be completely relied on to form a fully functional implant, and there 
is a need to develop approaches that promote appropriate ECM formation prior to implantation.  
Cues from tissue remodeling in pathological conditions may lead to better methods for functional 
tissue engineering of the bladder.   
The present study has demonstrated that the cells in the urinary bladder may be 
manipulated via varied stretch protocols and frequencies ex vivo to produce large quantities of 
the ECM proteins, collagen and elastin. These ECM proteins, particularly elastin, are of great 
interest in tissue engineering other smooth muscle tissues such as the airway and vasculature 
wherein the elastin is crucial to proper tissue function. The present study suggests that bladder 
smooth muscle cells may be manipulated via mechanical stretch on a synthetic or ECM-derived 
scaffold to produce the proper ratios of elastin and collagen for smooth muscle tissue engineering 
applications.     
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2.4.8 Summary  
This study has demonstrated that the ex vivo bladder wall responds to certain strain histories by 
upregulated collagen and elastin assembly. Specifically, fibrillar elastin was produced under a 
cyclic strain of 0.5 Hz (an increase of over 5-fold the amount found in the native bladder), while 
collagen was both synthesized and degraded within the bladder tissue at the same 0.5 Hz 
frequency. These results exemplify the effectiveness of utilizing an ex vivo organ culture model 
to understand strain-induced bladder wall remodeling, separating the effects of innervation and 
the tension associated with bladder filling from contractile forces. Furthermore, ex vivo organ 
culture of the bladder provides a means to understand strain-induced tissue remodeling that may 
be exploited in the future to tissue engineer UBW replacements. 
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3.0  THE EFFECT OF EXOGENOUS TGF-ß1 ON EX VIVO BLADDER 
EXTRACELLULAR MATRIX COMPOSITION AND SMOOTH MUSCLE CELL 
PHENOTYPE 
3.1 INTRODUCTION 
The urinary bladder wall undergoes extensive structural remodeling following pathologies which 
cause over distension and loss of controlled voiding. Following spinal cord injury (SCI) the 
bladder increases in size tremendously (Figure 3-1). The bladder smooth muscle hypertrophies, 
elastin content increases, and the biomechanical properties of the wall change material class, 
from isotropic to anisotropic [64]. It is unclear at present whether the detrusor is adaptive and 
compensating to an increase in volume from continual filling and irregular voiding, or whether 
the clinical symptoms of this increased volume and irregular voiding are due to the remodeling 
itself, which may occur as a result of the lack of innervation. As seen in the SCI affected bladder, 
the remodeling process appears in two phases. In the first phase, the bladder is areflexic and in 
the second phase spontaneous contractions begin to occur. In the areflexic phase the bladder is 
flaccid and tends to be over distended due to intermittent voiding [54]. Adam et al suggested that 
hypertrophy, or increase in bladder muscle mass, is due to sustained distension of the bladder 
wall [69].  While with the present data it is impossible to know the sequence and/or relationship 
of remodeling events, it is helpful to utilize in vitro organ culture models to examine the role of 
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molecules involved in or responsible for portions of the remodeling process. TGF-ß1 is one such 
molecule.  
 
A B
 
 
Figure 3-1. Photographs of excised bladders from A. Normal and B. SCI rats. Small ruler increments are in mm. 
3.1.1 Role of TGF-ß1 in disease state and fibrosis 
TGF-ß1 is a molecule often implicated in fibrosis and remodeling many tissues under 
pathological conditions. In the urinary bladder TGF-ß1 has gone largely overlooked in the 
disease state. Our laboratory has shown previously that TGF-ß1 gene expression is up-regulated 
only 3 days following SCI in the rat urinary bladder and continues to be up-regulated out to 21 
days post-SCI (Figure 3-2). The TGF-ß1 expression also correlates with expression of 
tropoelastin, lysyl oxidase, and IGF-1.  In other studies, TGF-ß1 has induced hypertrophy, up-
regulated collagen, and inhibited proliferation of BSMCs [144]. TGF-ß1 has been known to 
modulate cellular phenotype in fibrosis [145], and it has been shown to regulate the RHAMM 
protein as well as CTGF in the fibrotic bladder [68, 146]. Gene expression for TGF-B1 was also 
found to be up-regulated in a streptozotocin induced diabetic rat model [34]. Furthemore, TGF-ß 
up regulation has been found repeatedly in rat models and in patients who have bladder outlet 
 68 
obstruction [144], and it has also been found up regulated in the bladders of human patients with 
interstitial cystitis, urothelial cancer, and prostate cancer [147].  TGF-ß1 has also been 
administered to rabbit bladders and caused the fibroblasts within the lamina propria to 
differentiate into smooth muscle bundles [148]. Additionally, TGF-ß1 administered to human 
BSMC lead to an increase in stress fibers with a reduction of connexin-43 gap junctions [147]. 
Based upon these previous studies from our laboratory and others, it stands to reason that TGF-
ß1 may be a key regulator of tissue fibrosis and hypertrophy in the SCI affected bladder. 
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Figure 3-2. Gene array expression of key genes involved in ECM remodeling of the SCI bladder. [35]. 
3.1.2 Cellular phenotype shift 
The BSMCs are the most prevalent cell type in the urinary bladder wall. These cells require the 
maintenance of a contractile phenotype, commonly characterized by the expression of h-
caldesmon (h-CaD) and alpha-smooth muscle actin (α -SMA), in order to function properly to 
sustain muscular tone and produce coordinated contractions when signaled by stretch.  In certain 
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pathological conditions, , it has been reported that the BSMCs may experience a phenotypic shift 
from a more contractile to a more synthetic phenotype. In tissue culture on polystyrene plates, 
the BSMCs only retain their contractile phenotype for a limited number of cell passages, marked 
by a decrease in expression of h-CaD. Furthermore, in the vascular literature, a phenotypic shift 
of the SMC is thought to occur early on in culture as the cells begin to proliferate [138]. Since 
the nature of virtually all SMC in the body is to remain in a contractile, non-proliferative state, 
tissue culture of primary SMC shifts the cells into a proliferative and sometimes synthetic state. 
In the disease states of the bladder, there has been much controversy whether or not the BSMC 
hypertrophy or proliferate.  Hypertrophic smooth muscle cells express larger amounts of α –
SMA in comparison to normal, not hypertrophied cells [149].   
There has been an area of research recently that examines phenotypic shift in cells 
occurring in myofibroblasts. In the disease state, these myofibroblasts will shift from their 
normal, quiescent phenotype to an active, synthetic phenotype. The synthetic phenotype in the 
myofibroblast is characterized through increased expression of α –SMA and increased collagen 
production simultaneously [150].  In a collagen gel model, myofibroblasts contract collagen gels 
to a greater degree than fibroblasts [151]. Additionally, myofibroblasts with the addition of TGF- 
ß1 become more contractile [151]. 
The phenotypic shift occurring within BSMCs are not as clear. Firstly, the BSMCs retain 
a contractile phenotype in the healthy bladder. Second, the BSMC become synthetic in any 
unnatural state, i.e. in tissue culture or a pathological condition.  One theory is that the bladder 
smooth muscle cells differentiate toward myofibroblasts or a wound healing phenotype in the 
neurogenic bladder. This is supported via alterations in contractile proteins and synthesis of 
collagen [47]. However, this evidence is not consistent in all disease states. Evidence of a 
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phenotypic shift in smooth muscle cells has been found in the cardiovascular system [152], the 
kidney [153], and the airway [149, 154]. Mechanical stretch experiments on isolated BSMC have 
also shown that increased stretch will alter the BSMC phenotype by modulating cellular shape 
and actin reorganization [155]. Leask et al has shown that TGF-ß1 can modulate the cells toward 
a more synthetic phenotype [145]. Throughout the literature, the phenotypic shift of the BSMC 
does not appear to have concrete, common, characteristics other than that the cells become 
functionally less contractile.  There is thus a need to further explore the effect of mechanical 
stretch and TGF- ß1 on the phenotype of the BSMC to understand the shift that may occur in the 
disease state. 
The overall goal of the present study presented in this chapter was to accomplish the 
scientific endpoint of Specific Aim 2.1. This endpoint was to assess the role of TGF-ß1 with and 
without strip biaxial stretch on BSMC phenotype, ECM synthesis, and mechanical properties and 
compare these outcome measures to established data on the SCI rat bladder. The present study 
provides further evidence that TGF-ß1 is an important biological factor in the remodeling 
process. 
 
3.2 PROTOCOL 
3.2.1 Dynamic ex vivo organ culture 
Bladder strips were excised from female Sprague Dawley rats (2-3 mos.) and mounted in the 
tension bioreactor as described in Chapter 2. Nine bladder strips were stretched at 0.5 Hz , 20% 
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stretch for 7 days. Another nine bladder strips were statically floating in the bioreactor. To all 
groups, 1 ng/mL TGF-ß1 (R&D Systems) in RPMI 1640 media supplemented with 10% FBS 
and 1% PS. Media was changed daily. 
3.2.2 ECM assays 
At the end of culture time, bladder samples were removed and snap frozen in liquid nitrogen for 
biochemical assays or fixed in 10% neutral buffered formalin. Soluble collagen was assayed 
from the tissue and the media according to methods in Chapter 2. Elastin was also assayed with 
methods described in Chapter 2 
3.2.3 RT-PCR 
Messenger RNA extraction and RT-PCR were performed by the Pitt Genomics and Proteomics 
Core Laboratories, Pittsburgh, PA. Samples following culture at 0.5 Hz, n=3 per group, were 
snap frozen with liquid nitrogen and stored at -80 degrees C. mRNA extraction was isolated 
using RNAeasy kit. Ribonucleic acid concentration and purity were determined 
spectrophotometrically. The integrity of the RNA samples was confirmed by RNA integrity 
numbers that were greater than 5.0 according to the Bioanalyzer 2100 and the RNA Nano 6000 
LabChip kit (Agilent Technologies, Santa Clara, Calif). Ribonucleic acid samples (1 µg) were 
reverse transcribed to create complementary deoxyribonucleic acid (cDNA) at 42°C for 1 hour 
with the Superscript III First Strand Synthesis Kit (Invitrogen) and a Rotorgene thermal cycler 
(Corbett Life Sciences, Sydney, Australia). The cDNA samples were then amplified (40 cycles: 
90°C for 15 seconds and 60°C for 60 seconds) with the SYBR Green Master Mix (Invitrogen) 
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and custom designed PCR primer sets for type I collagen, type III collagen, and  tropoelastin in 
the Rotorgene thermal cycler (Table 3-1). Each sample was normalized to its amplification of 
Beta glucaronidase (beta gus). Furthermore, for comparison purposes the native group was 
averaged and used to normalize expression in the test group. Time permitted for only the 0.5 Hz 
group and the native bladders to be tested. 
 
Table 3-1 PCR primers 
 Sense Anti-Sense 
Type I collagen 5'- TCCTTTCTCCACCCCCTC -3' 5'- TCCTGTGTCTTTGGGGGA - 3' 
Type III collagen 5'-GTCTTATCAGCCCTGGTT C-3’ 5'-CCAGTATTCTCCGCTCTTGAGT-3'
Tropoelastin 5’-CCTGTCCCTGACTCCCATTA-3′ 5′-CAGTGTGAGAAGTCGTCGGA-3′ 
Beta glucaronidase 5' -GCCTTCATT TTGCGAGAGAG - 3' 5' -ACGGTCTGCTTCCCATACAC -3'
 
3.2.4 Mechanical testing 
Due to extreme preconditioning from stretching the bladder strips in the longitudinal direction in 
culture for 7 days, mechanical testing was performed using a strip-biaxial testing system as 
described previously [127]. With this set up, the bladder strips were mounted to the bars of the 
testing device using the stainless steel spring grips that were also used to stretch the sample in 
culture. Four graphite markers were placed in a square in the center of the specimen.  For passive 
and inactive testing, the bladder strips were stretched to 1.2 or 1.3 (for more compliant groups) 
while the deformation of the flexible bar was monitored. For decellularized testing, the bladder 
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strips were stretched until the tension stretch curve moved out of the linear elastic region, (on 
average to 1.35).  
 
Figure 3-3. Mechanical testing set up [127] 
 
Table 3-2. Mechanical testing conditions for bladder strips following culture 
Testing case Conditions 
Active Testing under physiologic conditions, Kreb’s 
solution at 37 degrees C, bubbled O2, stretched 
to 20% prior to the addition of XmM 
carbachol. Active contraction was measured by 
bar deformation. 
Passive Testing under physiologic conditions, 37 
degrees C, bubbled O2 
Inactive Testing in room temperature PBS following an 
overnight in modified Kreb’s. 
 
Decellularized 
Testing under inactive conditions following 
week long decellularization protocol. 
 
3.2.5 Bladder decellularization 
Following inactive mechanical testing bladder strips were decellularized according to a modified 
protocol from Nagatomi et al. Briefly, bladders were immersed in hypotonic Tris buffered saline 
(pH 8.0; Sigma) with 0.1 M Phenylmethanesulfonyl fluoride (PMSF, Sigma) for 28 hours. 
Second, the bladders were transferred into new solution with the Tris buffered saline, PMSF, and 
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the addition of 1% Triton X-100 (Sigma) for 44 hours. Finally, the bladders were transferred into 
new Tris solution with PMSF and 0.1% SDS (BioRad) for 28 hours. At the end of the 
decellularization process, the bladder strips were rinsed in PBS for 30 min and then tested at 
room temperature in PBS.  
3.2.6 Immunohistochemistry  
Sections of bladder tissue from 10-day, post-surgical spinalized female Sprague-Dawley rats 
were obtained from a previous study.[54]   Three bladders from each test group were fixed in 
10% neutral buffered formalin overnight and then transferred to PBS until processing could be 
performed. Samples were paraffin embedded and sectioned en face. Three slides per sample 
were used for each antibody stain. Slides were deparaffinized in 2 changes of xylene followed by 
a graded ethanol re-hydration. Antigen retrieval was performed using a Citrate EDTA buffer 
(10mM Citric Acid, 2 mM EDTA, 0.05% Tween 20, pH 6.2) at 95 degrees C for 30 minutes. All 
sections were blocked in 2% BSA for 1 hour prior to antibody application. For the TGF-ß1 
antibody staining, 5 µm sections were incubated with an anti-TGF-β1 primary rabbit polyclonal 
IgG antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA) and visualized with a 
streptavidin-Cy3 goat anti-rabbit IgG secondary antibody (1:1000; Jackson ImmunoResearch 
Laboratories, West Grove, PA).  For the alpha-SMA staining, sections were incubated in a 
monoclonal anti-actin, α-Smooth Muscle–FITC antibody produced in mouse (1:250, Sigma 
Aldrich). For the h- and general CaD staining, sections were incubated in either a monoclonal 
anti-caldesmon antibody produced in mouse (1:100, Sigma Aldrich) or a monoclonal anti-
caldesmon (smooth) antibody produced in mouse (1:100, Sigma Aldrich). The sections were then 
incubated with a rat biotinylated adsorbed anti-mouse IgG (1:500, R&D Systems). Finally, the 
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sections were rinsed in PBS and incubated with streptavidin-Cy3 (1:250, Sigma Aldrich). 
Following staining, the TGF-β1 sections and the caldesmon sections were incubated for 10 
minutes in 4´,6-diamidino-2-phenylindole, dihydrochloride (DAPI; Invitrogen). Slides were then 
visualized using a Leica DM IRB fluorescence microscope. All images were taken at the same 
exposure time for each group of antibody staining.  
 
3.2.7 Statistics 
All data are expressed as mean ± standard error of the mean (SEM), except for gene expression 
data, which is expressed in mean +/- standard deviation.  Data were analyzed by either the 
Student’s t-test or a one-way analysis of variance (ANOVA) followed by the Holm-Sidak 
method to detect statistical differences using SigmaStat software (Systat Software).  p<0.05 was 
considered statistically significant 
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3.3 THE EFFECT OF TGF-B1 IN EX VIVO ORGAN CULTURE 
3.3.1 TGF-ß1 antibody staining of normal, SCI-10 day, and cultured bladder strips 
As shown in section 4-3 there was more abundant staining of TGF-ß1 in the SCI 10 day bladder 
(Figure 3-4 D) compared to the native bladder (Figure 3-4 A). Additionally the 0.5 Hz stretched 
bladder (Figure 3-4 C) also expressed more positive staining for TGF-ß1 compared to the native 
bladder. The two experimental groups to which TGF-ß1 was added to the media had positive 
staining throughout the smooth muscle bundles and blood vessels (Figure 3-4 E,F). The statically 
cultured bladders without the addition of TGF-ß1 had no positive staining for the TGF-ß1 
antibody (Figure 3-4 B).  
 
 
Figure 3-4. TGF-ß1 antibody staining on en face bladder sections. A. Normal native bladder, B. Static culture 7 
days, C. 0.5 Hz culture 7 days, D. 10-day SCI bladder, E. Static culture + TGF- ß1 7 days, F. 0.5 Hz culture + TGF- 
ß1 7 days. Blue represent cell nuclei. Images are reduced from 200x. 
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3.3.2 Collagen and elastin in the cultured bladders 
As shown in section 2.3, the 0.5 Hz cycling of bladder strips at 20% stretch produced 
significantly higher quantities of elastin compared to the native bladder and statically cultured 
bladders. The addition of 1 ng/mL of TGF- ß1 did not alter elastin protein content in either the 
static or cyclically stretched culture groups compared to normal culture media treated groups 
(Figure 3-5).  The cyclically stretched group with the addition of TGF- ß1 still produced a 
significantly greater amount (p<0.01) of elastin compared to the native bladder (Figure 3-5). RT-
PCR was performed only on the native and the 0.5 Hz bladder group. The RQ values showed 
that the amount of tropoelastin gene expression was not significantly different between the native 
bladder and the bladders cycled at 0.5 Hz at 7 days (Figure 3-7). 
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Figure 3-5. Fold increase in elastin compared to the native bladder. Data are presented as mean +/- s.e.m. n=6 per 
group. *p<0.001 compared to native, + p<0.01 compared to native. 
 
There were significant differences in the amount of soluble collagen found within the 
bladder tissue when TGF- ß1 was added to the culture media in the 0.5 Hz stretch group (Figure 
3-6). There was significantly less soluble collagen found in the tissue in the 0.5 Hz group with 
regular media compared with the native bladder. In the media of the cultured bladder strips, there 
was a significantly greater amount of collagen when TGF- ß1 was added to the culture in the 
static group compared to the static group with regular media (Figure 3-6 B). There were also 
large amounts of collagen found in the media of both 0.5 Hz groups. RT-PCR data further 
indicate that gene expression for both collagen type I and collagen type III is significantly down 
regulated in 0.5 Hz cultured bladders at 7 days compared to normal native bladders (Figure 3-7). 
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This indicated that the collagen found in the media was likely broken down collagen in the 0.5 
Hz case. Further RT-PCR analysis would be necessary to determine the origin of the collagen in 
the media in the other test groups. 
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Figure 3-6. Soluble collagen protein found in A. bladder tissue of native and cultured bladders and B. media assay 
of soluble collagen. Data are presented as mean +/- sem with n=5-6 per group. 
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Figure 3-7. RQ values of RT-PCR gene expression for Type I collagen, Type III collagen, and elastin from native 
(black) and 0.5 Hz cultured bladders (gray). Data are presented as mean +/- st.dev. n=3 per group. 
 
 
Elastic trichrome staining of bladder segments revealed dense patches of elastin in the 0.5 
Hz cycled bladders with more disperse elastin seen in the 0.5 Hz + TGF-ß1 bladders (Figure 3-
8). Interestingly, the statically cultured bladders with the addition of TGF-ß1 had no clear lamina 
propria marked by the blue collagen staining above the smooth muscle bundles in all other 
groups. It appears that smooth muscle bundles made up the entirety of the cultured tissue with a 
larger portion of ECM separating what may have formerly been the collagenous lamina propria 
(Fig 3-8 C).    
Native
0.5 Hz, 7 days
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Figure 3-8. Elastic trichrome staining of A. native bladder, B. statically cultured bladder , C, statically cultured 
bladder + TGF- ß 1, D. 0.5 Hz cultured bladder, E. 0.5 Hz cultured bladder + TGF- ß 1. Images are reduced from 
200x. Red/purple are smooth muscle cells, blue staining is collagen, black staining is elastin. 
3.3.3 Mechanical properties of cultured bladder tissue 
The addition of carbachol for active testing only promoted a coordinated active contraction of the 
bladder strips in the freshly excised native bladders. Strip biaxial mechanical testing showed that 
all test groups retained some passive tone compared to inactive testing (Figs 3-9 and 3-11 A ). 
Static and cycled bladders with the addition of TGF-ß1 to the media exhibited greater 
compliance under passive and inactive testing indicated by the long toe region in the tension vs. 
stretch curves (Figs 3-9) and the statistically significantly (p<0.05) lower tension values at a 
stretch of 1.2 (Fig 3-11 A). In the decellularized tissue the static group had the largest tension 
values at a stretch of 1.2 that were significantly greater than all other groups (p<0.05). 
Furthermore, the 0.5 Hz groups with and without the addition of TGF-ß1 exhibited significantly 
lower (p<0.05) tension values at a stretch of 1.2 compared to all other groups indicating 
increased compliance in these decellularized bladder strips (Fig 3-10 B).   
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Figure 3-9. Representative tension vs. stretch curves of passive testing and inactive testing. 
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Figure 3-10. Representative tension vs. stretch curves of decellularized bladder tissue 
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Figure 3-11. Tension values at 1.2 stretch from strip biaxial biomechanical testing. A. Tension values from passive 
testing and inactive testing. B. Tension values following decellularization of the bladder strips. All data are 
presented as mean +/- se.m. with n=4 per group. In graph A, * indicates that the TGF-ß1 groups are significantly 
statistically lower (p<0.05) than all other groups within each testing mode. In graph B, * indicates significantly 
greater (p<0.05) than all other test groups, and # indicates significantly lower than native and static groups but not 
from each other. 
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3.3.4 BSMC phenotype  
En face bladder sections stained for markers of alpha smooth muscle actin (α-SMA), general 
caldesmon (CaD), and smooth caldesmon (h-CaD) showed that the native bladder positively 
expressed the contractile phenotype. The 10-day SCI bladders expressed greater levels of α-
SMA, CaD, and h-CaD than the normal bladders (Figures 3-12, 13, 14 A and D). Additionally, 
the 0.5 Hz cultured bladders expressed greater levels of α-SMA, CaD, and h-CaD than the 
normal bladders (Figures 3-12, 13, 14 C and A). The α-SMA appeared in stress fibers while the 
CaD and h-CaD appeared throughout the cells cytoplasm. These levels for the 0.5 Hz group 
appear to be equivalent to the staining in the 10-day SCI bladders for all three contractile 
markers. The statically cultured bladder strips treated with and without TGF- ß1 expressed little 
to no CaD, and h-CaD (Figures 3-13,14 B and E). Statically cultured bladders with and without 
the addition of TGF- ß1 expressed small amounts of α-SMA (Figure 3-12 B and E).  The 
dynamically cultured bladders with the addition of TGF-ß1 to the media expressed lower levels 
of α-SMA, CaD, and h-CaD than the dynamically cultured bladders with regular media (Figures 
3-12,13,14 F). Furthermore, the dynamically cultured bladders with the addition of TGF- ß1 
appeared to express even lower levels of the contractile proteins than the native normal bladder 
sections for all groups (Figures 3-12,13,14 F and A). However, the statically cultured bladders 
with the addition of TGF- ß1 expressed larger amounts of α-SMA than the statically cultured 
bladders in media alone yet no differences were apparent between the culture groups for h-Cad 
and Cad staining (Figures 3-12,13,14 B and E).  
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Figure 3-12.  Representative images from alpha smooth muscle actin (green)  staining of en face sections of A. 
Normal native bladder, B. Static culture 7 days, C. 0.5 Hz culture 7 days, D. 10-day SCI bladder, E. Static culture + 
TGF- ß1 7 days, F. 0.5 Hz culture + TGF- ß1 7 days. Images are reduced from 400x. 
 
Figure 3-13. General caldesmon (red) and nuclei (blue) staining of en face sections of A. Normal native bladder, B. 
Static culture 7 days, C. 0.5 Hz culture 7 days, D. 10-day SCI bladder, E. Static culture + TGF- ß1 7 days, F. 0.5 Hz 
culture + TGF- ß1 7 days. Images are reduced from 200x. 
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Figure 3-14. h-caldesmon (smooth) (red) and nuclei (blue) staining of en face sections of A. Normal native bladder, 
B. Static culture 7 days, C. 0.5 Hz culture 7 days, D. 10-day SCI bladder, E. Static culture + TGF- ß1 7 days, F. 0.5 
Hz culture + TGF- ß1 7 days. Images are reduced from 200x. 
 
3.4 DISCUSSION 
3.4.1 Alterations in ECM composition and mechanical properties 
The present study further confirmed that mechanical stimulation has a profound affect on the 
elastin content of the bladder strips in culture. However, the addition of TGF-ß1 to dynamic 
culture did not affect the elastin content within the samples. Since TGF-ß1 has been shown 
previously to stabilize the tropoelastin and lysyl oxidase molecules, this result was somewhat 
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surprising [145]. However, it is possible that since TGF-ß1 was up-regulated in the 0.5 Hz 
culture without any additional TGF-ß1 added the tropoelastin was already stabilized, and the 
elastogenic capabilities of the BSMC within the bladder strips were already maximized. The 
addition of TGF-ß1 to static culture did not promote any elastogenesis compared to all other 
groups. This finding suggests that the stimulus for elastogenesis was mechanical stimulation at 
the 0.5 Hz frequency.  Although there is a wide milieu of molecular mechanisms that may be 
altered in the bladder following SCI, the present study indicated that TGF-ß1 alone may not be 
responsible for the early change in elastin composition in the SCI bladder. 
The structural role of the elastin in the cultured bladders was exhibited in mechanical 
testing under a decellularized state. The 0.5 cyclically stretched bladders are significantly more 
compliant than all other groups, but not significantly different from each other. This may indicate 
that the elastogenesis in the cycled bladders plays a structural role in the biomechanical 
properties of the bladder; however, the tensions at a 1.2 stretch level appear to be governed by 
the SMC with both passive tone and inactive tone. Native bladders are stretched to larger stretch 
levels when filled, approximately 2.0 at maximum filling. The lamina propria has been reported 
previously to play a mechanical role at the beginning of filling and toward the end of bladder 
filling while the detrusor smooth muscle governs bladder biomechanics in between [24]. 
 TGF-ß1 did have an impact in the collagen composition of the cultured bladders. TGF-
ß1 is most commonly known as a promoter of collagen production leading to fibrosis of many 
organs [156].  The addition of TGF-ß1 to cultures of human BSMC increased both collagen type 
I and III protein expression at three different concentrations [156]. Other studies have shown that 
the diseased bladder produced primarily type III collagen under several disease conditions [157]. 
Our laboratory found previously, that dynamic culture of bladder strips at 0.5 Hz up-regulated 
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the expression of MMPs (See chapter 2). TGF-ß1 has also been shown to reduce MMP activity 
[145], which may have also led to the increase of soluble collagen within the tissue of the 0.5 Hz 
bladder strips compared to the marked decrease in soluble collagen that was found in the 0.5 Hz 
group in regular media. However, in contrast, MMP-2 has been shown to be up-regulated in 
airway SMC when treated with TGF-ß1 [158]. Therefore, while an increase in collagen protein 
levels was observed, mechanical properties did not necessarily follow the same pattern. 
Mechanical analysis of the bladder strips with and without treatment of TGF-ß1 revealed that 
strips exposed to TGF-ß1 with and without mechanical stimulation were more compliant than 
strips cultured in regular media under passive and inactive testing. However, the increased 
compliance in the passive testing conditions for both TGF-ß1 treated groups may have been due 
to the decrease in BSMC contractile proteins CaD and h-CaD.  The caldesmons are actin 
associated proteins thought to modulate contraction by mediating phosphorolation of the myosin 
[159]. The increased compliance in the inactivated bladder strips treated with TGF-ß1 in static 
culture may have been due to the increase in smooth muscle bundles in the lamina propria. As 
stated in Chapter 1, the lamina propria governs bladder compliance during initial stages of filling 
[2]. The increase in cells in this region likely altered the mechanical properties of the tissue in the 
inactivated state. The increased compliance in the dynamically cultured bladder strips with TGF-
ß1 may have been due to the decrease in stress fibers within the tissue. Even though inactive 
testing does not allow for smooth muscle tone, the BSMC remain in the tissue and the 
biomechanical properties of the tissue may be dependent on the cell matter that is remaining. 
When the bladder strips were decellularized the statically cultured bladders with the treatment of 
TGF-ß1 was significantly less compliant than all other groups. This finding showed that the 
actual ECM within the bladder strips was altered with the addition of TGF-ß1 to the culture.  
 90 
 
3.4.2 Phenotype 
Culture of bladder strips at 0.5 Hz, 20% without the addition of TGF-ß1 for 7 days mimicked the 
phenotype of the BSMC that was seen in the SCI bladders at 10 days. Increases in all contractile 
protein markers were seen compared to the normal native bladder. Furthermore, expression of 
TGF-ß1 was up-regulated in the 0.5 Hz group similarly to the 10 day SCI bladders. While no 
hypertrophy of the BSMC was seen in the cultured bladders, an increase in these contractile 
proteins, particularly h-CaD has been seen previously in hypertrophied smooth muscle [159].  
Increases in l-CaD along with a reverted fetal cell marker phenotype in SM1 and SM2 
[160] or in concert with increases in SM-A myosin heavy chain [161] have been seen previously 
following bladder obstruction. Varied changes in α -SMA and calponin expression have been 
observed in obstructed bladders [162]. Increases in thin filament proteins, calponin, caldesmon, 
and tropomyosin have been observed in the diabetic bladder [163].  
In the present study, exogenous TGF-ß1 added to culture decreased contractile proteins 
CaD and h-Cad. However, in static culture, the α-SMA appeared to be unchanged with the 
addition of TGF-ß1. An increase in alpha-SMA expression has been reported previously in static 
culture of isolated BSMC as well as aortic smooth muscle cells with the addition of TGF-ß1 to 
culture [144]. TGF-ß1 has also been shown previously to increase cell hypertrophy in an isolated 
BSMC study [156].   Furthermore the addition of TGF-ß1 to culture of BSMC increased α –
SMA expression but decreased connexin gap junctions [147]. The present study showed that the 
presence of mechanical stimulation clearly has an affect on the cellular phenotype of the BSMC 
within organ cultured bladder strips. The addition of TGF-ß1 may have caused more cellular 
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migration in the statically cultured bladder strips, or it may have caused the fibroblasts within the 
lamina propria to form bundles of what appeared to be smooth muscle. However, phenotypic 
staining showed no difference between these bundles and those in the bulk of the detrusor in the 
static + TGF-ß1 group. The decrease in contractile phenotype with the addition of TGF-ß1 to 
culture was further demonstrated by the passive and inactive mechanical testing where the TGF-
ß1 groups were significantly more compliant than all other groups.  
3.4.3 Relation to SCI affected bladders 
The present study showed distinct similarities between the 10 day SCI bladder and the bladders 
cultured at 0.5 Hz. Similarities were seen previously in elastogenesis and collagen content 
(Chapter 2). The present study highlighted more similarities in TGF-ß1, α-SMA, hCaD, and 
general CaD expression. Furthermore, similarities were seen in mechanical testing. Previous 
testing of SCI 10 day decellularized tissue under biaxial mechanical testing exhibited increased 
compliance compared to normal bladders [7]. In the present study, strip biaxial mechanical 
testing demonstrated increased compliance in the decellularized tissue cycled at 0.5 Hz. 
Although it remains to be understood exactly why the specific 0.5 Hz frequency promotes 
similar remodeling in both ECM composition and phenotypic change, it does appear that organ 
culture of bladder strips under mechanical stimulation may serve as an experimental model to 
examine cellular remodeling. 
The addition of TGF-ß1 to culture decreased bladder tone and caused more soluble 
collagen to be produced in the cultured bladders. The increase in collagen in these groups may be 
similar to the fibrosis seen in later stage SCI pathology [64]. There is no data to date that 
specifically shows the phenotype of long-term SCI detrusor BSMC, so it is unclear whether the 
 92 
change in phenotype that was seen in the present study can be correlated to changes in the SCI 
bladder. However, the addition of TGF-ß1 can clearly play a role in remodeling of the bladder 
detrusor.  The previous studies from our laboratory showed that TGF-ß1 expression remains up-
regulated out to 3 weeks post SCI while indicators of fibrosis do not appear until later [64]. The 
precise kinetics of how the TGF-ß1 signals the cells of the detrusor to promote collagen 
synthesis is unclear to date and may be the focus of future studies. With the knowledge to date 
we can speculate that the addition of TGF-ß1 to dynamic ex vivo organ culture of the bladder 
may mimic the SCI bladder at a later stage due to the decrease in contractile phenotype of the 
cells and the increase in collagen production compared to the other cycled bladders.  
3.4.4 Limitations 
Ideally in experiments examining the effect of cellular response to a growth factor, the 
experiments are carried out in little to no serum to differentiate effects that may be due to the 
multitude of serum proteins. In the present study, high fetal bovine serum (10%) was used in 
order to maintain cell survival in the organ culture strips.  Additionally, cultures of the bladder 
strips were only carried out to 7 days due to a trend toward migration of the BSMC out of the 
tissue seen at later time points (Chapter 2). A perfused bioreactor with oxygenated media may be 
the focus of future designs to examine later time points. Additionally, active contraction was not 
able to be measured due to the length of culture time only BSMC tone was able to be measured. 
It may be possible to examine earlier time points following mechanical stimulation to determine 
not only when the phenotypic shift occurs, but also if the phenotypic shift alters the contractility 
of the detrusor. 
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3.4.5 Summary 
The present study highlights the complexity of molecular signaling that occurs in bladder wall 
remodeling. The ex vivo system described in this study may be utilized in future research to 
examine the TGF-ß1 signaling cascade in the bladder that likely leads to fibrosis and stiffening 
following SCI. For other fibrotic diseases such as scleroderma, there have been studies underway 
to utilize antibodies to TGF-ß1 to prevent fibrosis [145]. With further study, the addition of 
TGF-ß1 antibodies to the diseased bladder may prevent stiffening of the bladder wall at early 
time points following SCI. Furthermore, the present study highlighted the importance of cellular 
phenotype on changes collagen synthesis. Further examination of the affect of TGF-ß1 on BSMC 
behavior is discussed in Chapter 4. 
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4.0  THE EFFECT OF TGF- β1 ON BSMC MEDIATED COLLAGEN GEL 
REMODELING 
4.1 INTRODUCTION 
The previous chapter described the impact of TGF-β1 on ECM composition and cellular 
phenotype in organ culture of the bladder. While it was noted that change occurred in the soluble 
collagen within the bladder strips, we were unable to quantify any changes in collagen 
architecture within the bladder. Our laboratory has shown previously that the bladder smooth 
muscle bundles hypertrophy following SCI such that the alignment changes from mostly 
longitudinal to both longitudinal and circumferential (Figure 4-1) [54]. With this change in 
directionality, it is probable that the collagen fibers also change in orientation. However, this 
change has never been quantified in vivo. Previous studies have isolated BSMC from neurogenic 
bladders and found that the BSMC possess increased proliferation, reduced cell adherence, and 
decreased contractility [164]. Additionally, BSMC become synthetic and produce large 
quantities of ECM proteins in the pathologic bladder. These components of tissue remodeling 
both the biochemical and biophysical are the result of changes in the bladder cell phenotype [35, 
68]. As shown in the previous chapter, the phenotype of the BSMC may be altered with the 
addition of TGF-β1.    
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Figure 4-1. Polar plots of directionality of smooth muscle bundles in normal A. and SCI B. bladders. [54] 
 
 The importance of TGF-β1 in bladder fibrosis and disease was detailed in the previous 
chapter. Additionally, TGF-β1 has also been implicated in other organs disease remodeling 
response. For this reason TGF-β1 has been utilized in isolated cell studies to examine its effects 
on a number of cell functions. Particularly when examining the impact of TGF-β1 on cellular 
response, a simplified experimental model may be utilized. Furthermore, the effect of TGF-β1 
may be examined in a low serum case in a cell culture setting that was not possible in the organ 
culture studies due to decreases in organ strip survival. The present study in this chapter focused 
on exploring the effect of TGF-β1 on collagen type I gel contraction and organization of the 
collagen fibrils within the gel. 
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4.2 PROTOCOL 
4.2.1 Cell culture 
 Rat BSMCs were derived from female Sprague-Dawley rats (2-3 months old) according to a 
method by [165]. Briefly, the mucosal layer of the bladder was removed, and the remaining 
tissue was minced. The minced bladder tissue was placed in RPMI 1640 (Invitrogen) medium 
containing 0.1% collagenase Type I-A (Sigma) and 0.2% trypsin (Invitrogen) in a Petri dish then 
incubated at 37 degrees for 30 minutes. The mixture was then filtered through a 100 um cell 
strainer and centrifuged at 1200 rpm for 3 minutes. Supernatant was discarded and the pellet was 
then re-suspended in complete media.  Cells were cultured in RPMI 1640 medium (Invitrogen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT) and 1% 
antibiotic/antimycotic (Invitrogen, Carlsbad, CA).  They were grown in cell culture flasks and a 
humidified atmosphere containing 5% CO2 at 37ºC.  Upon confluency, cells were rinsed with 1× 
Hank’s Balanced Salt Solution (HBSS; Invitrogen) twice and trypsinized with 0.12% trypsin-
EDTA (Invitrogen).  The cells were either passaged or counted with a hemocytometer for use in 
the experiments at three cell populations of 5×104, 1×105, and 2.5×105 cells (per collagen gel).  
All cells were used between passages 5 and 10 to minimize changes in phenotype from in vitro 
culturing. Prior to seeding, cell purity was assessed by confirming positive staining for 
antibodies to α-SMA and calponin. Cultures with approximately 99% cell purity were used for 
the experiments. 
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4.2.2 TGF-β1  
 Lyophilized TGF-β1 (R&D Systems, Minneapolis, MN) was reconstituted in a filter-sterilized 4 
mM HCl solution containing 0.1% bovine serum albumin (BSA) at 1 µg/ml.  The reconstituted 
solutions were frozen at –20°C for no more than three months prior to use.  1 ng/ml was used in 
all of the experiments.    
 
4.2.3 Anchored collagen gels  
Anchored collagen gels were utilized based on a previous protocol (Parekh et al, submitted).  
The collagen solution was cast in silicone molds (601 A/B mixture, Wacker Silicone, Lansing, 
MI) that were placed on glass coverslips in Petri dishes.  Steel mesh anchors (Small Parts, Miami 
Lakes, FL) were previously glued on to the glass coverslips with a silicone adhesive to provide 
uniaxial anchoring of the collagen gels.  The type I collagen gels, from the commercial product 
PureCol at 3 mg/ml (Inamed, Fremont, CA), were prepared as previously described to yield a 
final concentration of 2.4 mg/ml.  150 µl of collagen solution was polymerized in each mold in a 
humidified, 37°C chamber for one hour.  BSMCs were then placed on top of the collagen gels 
inside the molds in 400 µl complete medium.  The dishes were incubated for 30 minutes to 
ensure BSMC adhesion.  The silicone molds were removed, and 7 ml of culture medium, either 
control (2% FBS) or supplemented with 1 ng/ml TGF-β1, was added to each Petri dish.  The 
dishes were incubated for 30 minutes to allow the medium to equilibrate.   
 98 
The collagen gels with the highest seeding population of 2.5×105 cells routinely tore off 
one of the anchors by 24 hours with TGF-β1; therefore, these collagen gels were evaluated at 18 
hours.  Collagen gels were imaged at 0, 2, 4, and 18 or 24 hours using a dissecting microscope 
(Nikon, Melville, NY) and digital camera with capture software (PixeLINK, Ottawa, Ontario, 
CA).  The contraction of the anchored collagen gels was calculated based on the change in 
surface area when compared to t=0.  Collagen gel areas were measured with SigmaScan software 
(Systat Software, Richmond, CA) using a ruler for calibration.  Comparisons were made for the 
control versus TGF-β1 cases.  Collagen gel seeding and contraction calculation are shown in 
Figure 4-2. 
 
polymerize collagen 
(1 hr)
cells
cells attach 
(30 min)
loosen gels
medium
remove 
molds
% Contraction t=i =[(Area t=0-Areat=i)/Area t=0]*100  
 
Figure 4-2 Schematic of anchored collagen gels and calculation of % contraction of the gels. 
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4.2.4 Immunohistochemistry  
 For TGF-β1 staining, sections of bladder tissue from control and 10-day, post-surgical 
spinalized female Sprague-Dawley rats were obtained from a previous study [54].  5 µm cross- 
and lateral-sections were incubated with an anti-TGF-β1 primary rabbit polyclonal IgG antibody 
(1:200; Santa Cruz Biotechnology, Santa Cruz, CA) and visualized with a streptavidin-Cy3 goat 
anti-rabbit IgG secondary antibody (1:1000; Jackson ImmunoResearch Laboratories, West 
Grove, PA).  Samples were visualized with 20× fluorescent microscopy and captured with a 
digital camera and software (Olympus, Center Valley, PA).  TGF-β1 was quantified for control 
and SCI bladders in both orientations based on the ratio of TGF-β1 fluorescent area to total 
detrusor tissue area per section using Metamorph software (Universal Imaging, Downingtown, 
PA).   
For caldesmon staining, 1×105 BSMCs were seeded on glass coverslips in Petri dishes in 
a similar manner as the collagen gels (i.e., liquid volume spread out on an approximately 
equivalent surface area).  To mimic the collagen gel protocol, the dishes were incubated 30 
minutes to allow for BSMC attachment, 7 ml of control medium or medium with TGF-β1 was 
added, and the dishes were incubated for another 30 minutes to allow the medium to equilibrate.  
After 4 hours, the coverslips were rinsed with HBSS and fixed with 2% paraformaldehyde 
(Sigma).  The coverslips were incubated with either an anti-caldesmon primary mouse 
monoclonal IgG1 antibody (1:100; Sigma) or an anti-caldesmon (smooth) primary mouse 
monoclonal IgG1 antibody (1:100; Sigma) that bind either both caldesmon isoforms or the high 
molecular weight form, h-CaD, respectively.  The coverslips were incubated with a biotinylated 
 100 
rat adsorbed horse anti-mouse IgG secondary antibody (1:500; Vector Laboratories) and 
visualized with a streptavidin-Cy3 conjugate secondary antibody (1:250; Sigma).  Caldesmon 
was visualized using 400× fluorescent microscopy with a digital camera and software (Leica, 
Bannockburn, IL).   
 
4.2.5 Small angle light scattering (SALS)   
The anchored collagen gels were fixed in formalin at either 18 (for 2.5×105 cells) or 24 hours 
(for 5×104 and 1×105 cells).  The SALS technique was then performed on the collagen gels to 
ascertain collagen fibril organization.  The technique is well-developed and has been described 
previously [166] and has been used to quantify collagen gel reorganization (Parekh submitted).  
A 4 mW HeNe laser light (Uniphase, Manteca, CA) with a wavelength of 632.8 nm was passed 
through the collagen gel samples at a spatial resolution of approximately 250 µm.  The internal 
planar fibrillar architecture of the collagen gels causes a scattering of the laser light that is 
collected on a projection screen.  The resulting angular distribution of scattered light, I(Φ), can 
be used to quantify the fibrillar architecture of the collagen gels in terms of the preferred fibril 
direction ,Φc, and the orientation index, OI, of collagen fibrils.  SALS video images of the laser 
light scattering were collected, digitized, and analyzed with custom software.  The I(Φ) is 
interpreted by the software as a distribution of fibril angles corresponding to the positions within 
each collagen gel.  This analysis gives the Φc, the centroid of the distribution I(Φ), which is 
symbolized as a vector, and the OI, which is defined as the angle that contains 50% of the total 
fibrils.  Therefore, randomly oriented fibril networks result in large OI values while highly 
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oriented fibril networks result in small OI values.  The collagen gels were evaluated based on 
704 individual OI values at each point throughout the collagen structures then averaged to 
represent the physical remodeling of each collagen gel.  This area of evaluation was chosen to 
encompass the majority of the collagen gel but ignored the free edges and areas near the steel 
mesh anchors to avoid edge effects (Fig. 4-2).  The fibril orientation of these collagen gels was 
used for comparison between controls and TGF-β1 cases.  In order to confirm that changes in 
reorganization were due to changes in the collagen gel architecture, BSMCs were treated with 
0.25% trypsin for four days to detach all of the cells.  Images were taken before and after with 
the dissecting microscope to compare the effect of the BSMCs on the collagen gels. 
4.2.6 Cell morphology 
Cell morphology on the collagen gels was imaged and captured using 100× phase contrast 
microscopy with a digital camera (Nikon) and Metamorph software (Universal Imaging, 
Downingtown, PA), respectively at 4 and 18 or 24 hours depending on the cell seeding density.   
4.2.7 Statistics 
All data are expressed as mean ± standard error of the mean (SEM).  Data were analyzed by 
either the Student’s t-test or a one-way analysis of variance (ANOVA) followed by the Holm-
Sidak method to detect statistical differences using SigmaStat software (Systat Software).  
p<0.05 was considered statistically significant.  Data generated using multiple cultures of 
BSMCs were pooled together.        
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4.3  THE EFFECT OF TGF-β1 ON COLLAGEN GEL CONTRACTION AND 
ORGANIZATION 
 
4.3.1 TGF-β1 expression in SCI bladders 
Fluorescent antibody staining for TGF-β1 confirmed previous results wherein SCI bladders 
expressed greater amounts of TGF-β1 than normal bladders [35]. In the present study, TGF-β1 
area of staining was 5 fold greater in the cross sections and 2 fold greater in the lateral sections 
of SCI bladders than normal bladders (Figures 4-3, 4). The larger area of staining is diffuse 
throughout the bladder smooth muscle tissue (Figure 4-3). 
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Figure 4-3.  Fluorescent antibody labeling of TGF-β1 in normal and 10 day post-surgical SCI bladders in both 
cross- and lateral-sections indicates greater TGF-β1 expression in the SCI smooth muscle tissue. Bright structures 
are blood vessels. 
 
Figure 4-4.  TGF-β1 expression is quantitatively greater in the SCI tissue in both the cross- and lateral-sections.  
Expression was calculated as the ratio of total fluorescent area to total smooth muscle area.  n=48 for all cases but 
the lateral control case which was n=44.  Values represent mean +/- SEM and * indicates p<0.005. 
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4.3.2 TGF-β1 decreases contraction of collagen gels at early time points 
For all three cell populations, the BSMCs contracted over time (Figure 4-5). At 2 hours, 2.5×105 
BSMCs contracted the collagen gels by 11.0% versus 2.6% and 4.0% for 5×104 and 1×105 
BSMCs, respectively (p<0.05).  Collagen gel contraction remained higher at 4 hours for 2.5×105 
BSMCs versus 5×104 and 1×105 BSMCs, 19.1% versus 4.1% and 7.6%, respectively (p<0.05).    
However, at 24 hours, no significant differences were found among the three groups; contraction 
was 20.3%, 20.0%, and 24.4% for 5×104, 1×105, and 2.5×105 BSMCs, respectively.     
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Figure 4-5.  Basal BSMC contraction of anchored collagen gels is greater for the highest population of cells at 2 
and 4 hours.  All anchored collagen gel assays were performed using the three cell populations in control 
conditions (RPMI 1640 and 2% FBS).  n=13-18, 16-21, and 9-17 for 5×104, 1×105, and 2.5×105 BSMCs, 
respectively.  Values represent mean +/- SEM and * indicates p<0.05. 
 
 
With the addition of TGF-β1 to culture, cellular contraction of the collagen gels was 
significantly inhibited for all three cell populations at both 2 and 4 hours following seeding 
(Figure 4-6). Positive staining for general caldesmon was seen in both regular media and TGF-
β1 treated groups (Figure 4-7). Slight phenotypic differences were visualized in the expression of 
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h-caldesmon following 4 hours of exposure BSMC exposure to TGF-β1 on glass coverslips 
(Figure 4-7). Following light microscopy imaging, BSMC were trypsinized from the surface of 
the collagen gels. Figure 4-12 shows the trypsinized gels. The gels retained their contracted 
shape and visible white regions of collagen alignment following the removal of the cells (Figure 
4-12). 
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Figure 4-6.  TGF-β1 inhibits contraction of anchored collagen gels by (A) 5×104, (B) 1×105, and (C) 2.5×105 
BSMCs.  Anchored collagen gel contraction was assessed in control conditions with and without 1 ng/ml TGF-β1.  
n=8-18, 10-21, and 7-17 for 5×104, 1×105, and 2.5×105 BSMCs, respectively, for the control and TGF-β1 cases.  
Values represent mean +/- SEM and * indicates p<0.05. 
 
 
 
Figure 4-7.  Fluorescent antibody labeling of caldesmon (both isoforms) and h-CaD in BSMCs after 4 hours on 
glass coverslips for control and TGF-β1 cases.  Caldesmon labels intensely in the actin cytoskeleton and cytoplasm 
for both cases, whereas h-CaD staining is less intense, cytosolic, and further diminished in the TGF-β1 case. 
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(A) (B)  
 
Figure 4-8.  (A) An example of a contracted anchored collagen gel between the steel mesh anchors 5×104 BSMCs 
after 24 hours.  (B) SALS image of the same collagen gel.  Dotted box depicts area of analysis containing the 704 OI 
values averaged to represent the physical remodeling or reorganization of each collagen gel.  Areas of red depict 
highly oriented fibril networks (corresponding to small OI values), whereas areas of blue indicate randomly 
oriented fibril networks (corresponding to large OI values). 
 
Figure 4-9.  TGF-β1 increases collagen gel alignment and orientation (smaller OI values) for 2.5×105 BSMCs.  
2.5×105 BSMCs physically remodel and organize the collagen gels (smaller OI values) more than the other two 
BSMC populations (not shown statistically on graph).  OI values were assessed after 24 hours of contraction for the 
5×104 and 1×105 BSMCs and 18 hours for the 2.5×105 BSMCs.  n=4-7, 5, and 8-9 for 5×104, 1×105, and 2.5×105 
BSMCs, respectively, for the control and TGF-β1 cases.  Values represent mean +/- SEM and * indicates p<0.005. 
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4.3.3  TGF-β1 alters collagen reorganization 
SALS scanning showed that contracted collagen gels had aligned collagen fibrils along the edges 
indicated by the pink regions of the SALS scans (Figure 4-8). The addition of TGF-ß1 increased 
the organization of collagen gels at the highest cell population (Figure 4-9). Representative 
SALS scans show the areas of higher alignment (red and pink) in the TGF-ß1 treated higher cell 
populations (Figure 4-10). 
 
4.3.4 TGF-β1 causes BSMC bundling 
The regions of higher alignment in Figure 4-10 c right panels appear to correspond to the white 
regions seen in Figure 4-10 c left panels. Light microscopy images of the BSMC on the collagen 
gels with and without the addition of TGF-β1 are shown in Figure 4-11. These images showed 
that the addition of TGF-β1 to the middle and high cell populations causes bundling of the 
BSMC on the surface of the gel. Further SALS scanning showed that these regions of cellular 
bundling corresponded to regions of high collagen alignment within the gel (Figure 4-10).  
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Figure 4-10.  Contracted anchored collagen gels and accompanying SALS images for control and TGF-β1 cases for 
(A) 5×104 BSMCs at 24 hours, (B) 1×105 BSMCs at 24 hours, and (C) 2.5×105 BSMCs at 18 hours.  Highly aligned 
areas of collagen fibrils (red) increase with increasing cell populations and are more prominent at higher cell 
populations.  TGF-β1 induces the formation of white patches on the collagen gels (B, C). 
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Figure 4-11.  Cell morphology on anchored collagen gels for (A) 5×104, (B) 1×105, and (C) 2.5×105 BSMCs at 4 
and 24 hours for control and TGF-β1 cases.  Spreading depends on cell population with a higher number of cells 
spreading faster on the collagen gel surfaces at 4 hours and maintaining this morphology at 24 hours in the control 
cases.  By 24 hours, the majority of BSMCs are spread and elongated in the control conditions.  However, TGF-β1 
induces cell bundles or aggregates (B, C) which correspond to white patches on the collagen gels and regions of 
high collagen fibril alignment. 
 
 
 
 
Figure 4-12.  An anchored collagen with 2.5×105 BSMCs after (A) 18 hours of contraction and followed by (B) 4 
days of trypsinization shows that the changes in collagen gel architecture caused by the BSMC aggregates are 
conserved. 
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4.4 DISCUSSION 
4.4.1 Influence of TGF-β1 on gel contraction and cellular phenotype 
As discussed in chapter 3, the contractile phenotype of BSMC within the organ cultured bladder 
strips was decreased following culture with the addition of TGF-β1 to the media daily. The study 
discussed in this chapter further demonstrated this phenotypic shift of the BSMC with the 
addition of TGF-β1. TGF-β1 decreased BSMC mediated gel contraction at early time points. 
Additionally, TGF-β1 decreased expression of the contractile maker h-CaD. At the highest cell 
population, TGF-β1 eventually increased gel contraction at 18 hours with the gels torn off of the 
anchors at 24 hours. The increase in gel contraction appears to have been due to the cells forming 
rudimentary bundles on the collagen gels. These rudimentary bundles have been observed 
previously when TGF-β1 was infused into a rabbit bladder in vivo [148].  This change in gel 
contraction may have also been due to the effects of the TGF-β1 being metabolized by the high 
cell population at a faster rate than in the low and middle cell populations. As stated in a 
previous section, the contractile phenotype of the BSMC does diminish over time in culture. 
Cells utilized in this study were seeded from passages 4-8. In preliminary studies from our 
laboratory, the contractile phenotype marked by the expression of h-CaD is diminished at 
passages greater than 10. The cells in culture are automatically pushed toward a less contractile 
phenotype, but this predisposition was minimized as much as possibly by using the cells at 
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relatively low passage numbers. The antibody staining for h-Cad was further diminished with the 
addition of TGF-β1 giving further evidence of a phenotypic shift.  
 
4.4.2 Influence of TGF-β1 on collagen gel organization 
The collagen alignment of the BSMC was again much lower than alignment found utilizing other 
cell types (Parekh submitted); however, the OI values seem to be consistent with smaller 
contraction under basal conditions. Although the addition of TGF-β1 to the BSMC on the 
collagen gels diminished the cellular contractile phenotype and decreased the rate of collagen gel 
contraction at 2 and 4 hours, an increase in collagen alignment was seen compared to the 
collagen alignment found within the BSMC seeded gels in regular media. It was also observed 
that these values were not consistent throughout the collagen gels. The increased areas of 
alignment corresponded to the areas of the BSMC rudimentary bundles even after extensive 
trypsinization. These areas of high alignment were evidence that TGF-β1 has local physical 
remodeling effects on the BSMC. Localized physical remodeling of the gels was further 
observed by the collagen gels tearing off of the anchors at the high cell population at 18 hours. It 
is possible that instead of the cells regaining a contractile phenotype as the effects of TGF-β1 
diminished, the BSMC formed such tight bundles that holes appeared in the collagen gels. This 
local physical remodeling of the collagen orientation by the BSMC may be akin to the 
remodeling that our laboratory has observed previously in the SCI affected bladder at 10 weeks 
[54]. 
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4.4.3 Implications 
The overall changes in cellular phenotype with the addition of TGF-β1 may be of great 
importance to understanding the vast changes in ECM seen in various pathologies affecting the 
bladder wall. While the precise role of a phenotypic shift in the bladder under SCI or any 
pathology is not currently understood, we can speculate based upon our current findings that the 
phenotypic shift alters the relationship between the cells and the ECM causing dysfunction. This 
shift in phenotype may be chemically modulated by TGF-β1. It is important to note that the 
behavior of the BSMC on the collagen gel may have implications for engineered tissues. The 
regulation of ECM synthesis by both biochemical and biophysical factors must be closely 
monitored in order to engineer a tissue with proper ECM and BSMC organization and 
composition. 
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5.0  IN VITRO MECHANICAL CONDITIONING OF BSMC SEEDED ON SIS 
5.1 INTRODUCTION 
The most successful approaches to tissue engineering the urinary bladder wall utilize 
biodegradable scaffolds seeded with autologous cells. Although this technique has proven 
successful in increasing bladder capacity and decreasing the pressure build up that ultimately 
leads to kidney damage, problems remain with lack of proper tissue organization post-
implantation, impairing the bladder’s ability to maintain its full function. Small intestinal 
submucosa (SIS) has been utilized previously to engineer the urinary bladder wall with and 
without cell seeding. These previous studies have shown that in order to maintain graft size, 
seeding of the SIS prior to implantation is necessary [105].  In order to engineer a functional 
tissue replacement for the bladder wall with controlled ECM production and proper BSMC 
alignment for contraction, mechanical stimulation may be necessary. However, mechanical 
stimulation of cell seeded SIS is difficult due to the long periods of time it takes for BSMC to 
penetrate the SIS so that it may be stretched. 
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5.1.1 Previous SIS studies 
 
Prior studies have suggested that seeding SIS with autologous cells may be advantageous in 
regenerating functional and mechanically sound tissue replacements.  Autologous skeletal 
muscle cells suspended in a collagen gel seeded onto SIS showed higher mechanical tensile 
strength than unseeded SIS when implanted into the abdominal muscles of Lewis rats [107]. In 
addition, using a de-cellularized bladder matrix seeded with canine autologous urothelial and 
bladder smooth muscle cells for bladder augmentation resulted in an increase bladder capacity 
[108] and a more complete retention of implanted diameter [109] compared to unseeded matrix. 
These studies provide evidence that a tissue engineering approach, utilizing autologous cells and 
a 3-D, biological scaffold, toward urologic tract repair and replacement may provide better long-
term successes. Previously our laboratory demonstrated in vitro, muscle derived stem cells 
(MDSC) seeded on SIS formed a calcium-dependent contractile muscle-like tissue after 4 weeks 
in culture [167]. Additionally, we found that MDSC-seeded SIS after 10 and 20 days in culture is 
more compliant when compared to unseeded SIS as demonstrated through biaxial mechanical 
testing, but there was no change in mechanical compliance between 10 and 20 days of seeding 
[168]. To date, however, the mechanisms by which the MDSC remodel the SIS construct have 
yet to be elucidated.   
 One possible mechanism vital to the initial remodeling event is the release of matrix 
metalloproteinases (MMPs). MMPs are a family of zinc dependent proteolytic enzymes that 
function mainly in the ECM, where they contribute to the development, functioning, and 
pathology of a wide range of tissues [169]. Since collagen type-I is the main component of SIS, 
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it is possible that MMP-I plays a role in the interaction of MDSC with SIS during the initial 
remodeling process.  Other studies have shown that MMP-2 and –9 may play a role in the break 
down of collagen type-I [170]. However, MMP-2 and –9 are active in degrading gelatin, which is 
the byproduct of collagen-I cleavage by MMP-I  [169]. Since MMP-I acts on fibrillar collagen-I 
before MMP-2 and –9 are activated, we chose to examine MMP-I as our potential mechanism 
responsible for the initial remodeling event marked by an increase in mechanical compliance. 
We hypothesize that the release of MMPs and the resultant break-down of collagen fibers by 
MDSC seeded onto SIS is a potential mechanism responsible for the initial event in the 
remodeling process, signaled by an increase in mechanical compliance observed in our previous 
study [168]. In a previous study, we previously examined the role of MMP-I in the initial 
remodeling events, specifically studying the activity of MDSC seeded onto SIS as well as the 
impact of MMP-I on the mechanical properties of SIS.  
 
Figure 5-1. Scanning electron microscopy images of control SIS (a), SIS digested with collagenase-I for 5 hours (b), 
MDSC on SIS for 24 hours (c), and MDSC on SIS for 7 days in culture (d).[171] 
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The luminal surface of SIS appeared as a smooth surface with visiable aligned collagen 
fibers (Fig. 5-1 A). When exposed to collagenas-I this surface becaome very rough with collagen 
fibers disrupted (Fig 5-1 B). MDSC seeded on SIS remained on the surface of the SIS and 
formed cell-cell protrusions (Fig 5-1 C) and eventually formed large groupings on the surface of 
the SIS (Fig 5-1 D). The MMP assay revealed that MMP-I activity (Fig. 5-2a) of the MDSC 
seeded SIS was significantly higher (p<0.0025) after one day in culture compared to samples 
collected from subsequent time points and the unseeded control.  Supernates from MDSC seeded 
on tissue culture polystyrene expressed a significantly higher amount of MMP-I activity 
(p<0.025) after 3 and 5 days in culture and (p < 0.0025) after 7 and 10 days in culture compared 
to MDSC on SIS and SIS alone at corresponding time points.  Additionally, there was a 
significant amount (p<0.05) of MMP-I present in supernatant from soaked, unseeded SIS 
compared to media alone (Fig. 5-2b). 
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Figure 5-2.  Normalized MMP-I activity of supernates of (a) MDSC on SIS and MDSC on tissue culture polystyrene 
and (b) SIS alone.  In b, SIS releases residual MMP-I, which decreases linearly over time. Data are mean ±SEM n = 
3 per group in triplicate. [171] 
 
 When tested biaxially, SIS exhibited the classic non-linear stress-strain response common 
to soft tissues. All specimens tested were in a state of nearly pure biaxial strain with negligible 
shear. Mechanical anisotropy, different response to equi-biaxial stress between the longitudinal 
and circumferential directions, was found in each group. Samples that were incubated for 24 
hours in media containing collagenase-I could not be tested due to the nearly complete break 
down in the collagen type-I fibers of the SIS. After 3 and 4.5 hours of digestion with collagenase 
I, the SIS had no significant change in compliance in either the circumferential or longitudinal 
directions compared to SIS soaked in media alone. After 5 hours of digestion with collagenase-I, 
mechanical compliance under 1 MPa peak stress was increased by 7% in the circumferential 
direction, compared to control SIS (Fig 5-3). Peak stretch in the longitudinal direction (Fig. 5-3) 
did not change with digestion.  Areal strain was significantly greater (p<0.007) after digestion 
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with collagenase-I for 4.5 and 5 hours when compared to the control. Additionally, there was no 
significant difference (p=0.356) in areal strain between SIS digested for 5 hours and SIS seeded 
with MDSC for 10 days. These results from this study supported our initial hypothesis, that the 
MDSC synthesize and release MMP-1 into the ECM to digest the SIS substrate early in the 
remodeling process, which may allow the cells to attach, penetrate and integrate into the 
substrate. The break down of collagen fibers may lead to the increase in compliance of the 
MDSC seeded SIS. However, the MDSC did not further utilize this mechanism to penetrate the 
SIS. 
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Figure 5-3. Representative plot of equi-biaxial testing experiments in the longitudinal direction (a) and 
circumferential direction (b) on SIS digested with 0.16 U/mL collagenase-I for 5 hours, MDSC seeded SIS for 10 
days, and control. 
 
 
While interesting from a biological perspective, the aforementioned study was not useful 
for tissue engineering or utilizing the system to examine the mechanobiology of cell-seeded SIS 
due to the lack of penetration of the MDSC into the SIS. Other studies utilizing bladder smooth 
muscle cells (BSMC) seeded on an ECM scaffold (SIS or bladder acellular matrix) proved that 
cellular penetration was difficult to achieve in vitro without the use of co-culture with urothelium 
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[94, 140]. Other studies have also shown that cell penetration into SIS takes on the order of 
weeks (REF).  In order to obtain a construct that may be mechanically stimulated to promote 
ECM remodeling, cell penetration is necessary. Although the exact signaling mechanisims 
between the urothelium and BSMC in culture are unclear, it has been noted previously that 
soluble growth factors are likely involved [172]. Therefore in order to increase cellular 
penetration, growth factors that are released in culture by the urothelium may be utilized. 
 
5.1.2 Growth factors VEGF and FGF-2 
SIS itself contains a number of growth factors and cytokines. Among the most abundant are 
basic fibroblast growth factor (bFGF or FGF-2) and transforming growth factor beta (TGF-ß) 
[173].  SIS also contains other factors such as vascular endothelial growth factor (VEGF), but 
VEGF is degraded in the processing of the matrix [174].  These growth factors and cytokines 
likely aid in the remodeling response that occurs following implantation of SIS; however, in 
vitro, the inherent growth factors in the SIS may not be adequate to promote penetration of cell 
types other than fibroblasts.   
FGF-2 is expressed in cell types from the mesoderm and neuroectoderm [175].  FGF-2 
has additionally been shown to play a role in angiogenesis, proliferation, and differentiation in 
nearly every organ system [175]. FGF-2 has been identified to play a crucial role for stimulating 
skeletal muscle regeneration [176]. It has also been demonstrated that FGF-2 retains its 
bioactivity in SIS following processing [174]. The growth factors FGF-2 and VEGF simulate 
urothelial cell presence [142], have been shown to  increase proliferation in neruogenic BSMC 
 122 
[177] and have an anti apoptotic effect in culture of human BSMC [72]. Additionally, VEGF 
plays a role in bladder development [172].  
For these aforementioned reasons, we hypothesize that the growth factors VEGF and 
FGF-2 may be utilized to increase cellular penetration into the SIS. Furthermore, we hypothesize 
that BSMC seeded SIS exposed to mechanical stimulation will produce significant changes in 
the amount of ECM components collagen and elastin dependent on the frequency of stretch.  
 
5.2 PROTOCOL 
5.2.1 Cell culture 
 Bladder smooth muscle cells (BSMC) were isolated from female Sprague Dawley Rat bladders 
as described previously [165] and expanded in culture in RPMI 1640 media with 10% FBS and 
1% Pen/Strep. All cells were used between passages 6-9 and seeded at 0.5x106 cells/cm2 onto 
the luminal side of SIS inserts (Cook Biotech). A pilot study was performed wherein 2 
concentrations of VEGF (low 10 ng/mL and high 20 ng/mL; Sigma) and 2 concentrations of 
FGF-2 (low 5 ng/mL and high 10 ng/mL; Sigma) were utilized based upon concentrations 
reported previously in the literature. A DNA quantification assay was performed at 7 days in 
culture and no significant differences in cellular proliferation were observed between the low and 
high concentrations. Therefore, VEGF (10 ng/mL) and FGF-2 (5 ng/mL) were added to each 
insert in the media every other day for up to 7 days in culture. Following culture in growth factor 
treated media, samples were switched to regular culture media (RPMI 1640 supplemented with 
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10% FBS and 1% PS) and then either grown in static culture or dynamic culture for an additional 
7 days.  
 
5.2.2 Mechanical stimulation  
Following 7 days in static culture with the exogenous growth factors, BSMC seeded SIS was 
affixed with tissue grip springs to a tension bioreactor as described previously [150] and 
stretched at 15%, 0.1 Hz or 15%, 0.5 Hz under strip biaxial stretch with the primary direction of 
stretch in the longitudinal direction , for an additional 7 days. 
 
5.2.3 DNA quantification 
Following static and dynamic culture samples were snap frozen and stored at -80 C for 
biochemical assays. DNA quantification was performed as described previously [171]. Each 
sample was cut into fourths and weighed prior to extraction. Samples were placed in a 
microcentrifuge tube and extracted in 1 ml of 0.125 mg/ml papain solution for 10 hours in a 60 
0C water bath. Digested samples were analyzed with a PicoGreen dsDNA quantitation kit 
(Molecular Probes, Eugene, OR) as per the manufacturer’s instructions and using the blue 
channel of a TBS-380 Mini-Fluorometer (Turner Biosystems, Sunnyvale, CA). There was a 
small amount of DNA found in the unseeded SIS scaffold; this amount was subtracted from the 
DNA found in each sample. The total DNA quantitation was done in triplicate with n=3 per 
group. 
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5.2.4 Collagen and elastin assessment 
Collagen and elastin concentrations were determined based on techniques adapted from Brown et 
al [128], which have previously been used to quantify ECM synthesis of ovine vascular smooth 
muscle cells under cyclic mechanical flexure [129]. Soluble collagen was extracted from tissue 
samples using a solution of 0.5 M acetic acid (Sigma) and 1 mg/mL Pepsin A (Sigma). Each 
sample was placed in a microcentrifuge tube and incubated in 1 ml of extraction solution 
overnight (~16 h) on a rocker table operating inside a refrigerator at 2–8°C.  Elastin was 
extracted using a hot oxalic acid treatment. The supernates from the oxalic acid treatments were 
loaded onto Centricon RC/YM-3 centrifugal filter units (Millipore, Bedford, MA) and 
centrifuged at 3000g for an additional hour. The concentrate was then be re-suspended in cold 
(<5°C) Elastin Precipitating Reagent (UK Biocolor). Soluble collagen from the collected media 
samples at days 2, 4, 6, 8, 10, 12 and 14 was precipitated with 4 M NaCl. Fresh media was used 
as the control. Following the extraction steps, the collagen and elastin extracts were assayed 
according to the guidelines provided with the Sircol™ and Fastin™ assay kits, respectively (UK 
Biocolor).  
 
5.2.5 Matrix metalloproteinase (MMP) activity  
Since the pepsin soluble collagen found in the tissue may be either newly formed collagen or 
degraded collagen, the culture media was assayed for both collagen and bulk matrix 
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metalloproteinase activity. MMP activity was assayed from the conditioned media at days 2, 4, 6, 
9, 11, 13 utilizing a similar method to Aitken et al 2006 [130]. Net activity was assayed using the 
EnzCheck collagenase/gelatinase assay kit (Invitrogen). DQ-gelatin fluorescein conjugate (0.1 
mg/mL) was incubated in Tris buffer (50 mmol/L) with conditioned media for 2 hours. The 
MMPs then released the quenched activity of the FITC from the FITC-gelatin. The released 
FITC was measured on a fluorescent microplate reader at 495 nm absorption and 525 nm 
excitation. Collagenase produced in Clostridium histolyticum provided in the kit was used as a 
positive control. Negative controls were performed with 20 µmol/L of 1,10-phenanthroline to 
inhibit the MMP activity. Background from SIS incubated in media was subtracted from all 
samples at corresponding time points. Data are reported as a summed total of activity from each 
day media was changed (2, 4, 6, 9, 11, and 13). 
 
5.2.6 Cell migration assays  
Migration of the BSMC was assessed in two ways. First, BSMC were seeded at 0.5 x 10 6 
cells/cm2 on SIS. 3 samples at 2, 4, and 6 days following culture were fixed in 10% NBF for 
sectioning and nuclei staining to visualize nuclei distribution in the SIS.  Additionally in order to 
quantify the effects of VEGF and FGF-2 on cellular migration without confounding effects of the 
inherent growth factors in SIS, cells were seeded on Costar Transwell Inserts ( 6.5 mm, 8µm 
pore size, Fisher Scientific) coated overnight at 4 C with Type I collagen (PureCol). Following 
coating, the collagen was aspirated and inserts were dried under a laminar flow hood for 4 hours. 
Cells were seeded at 4x104 cells/mL in either 10ng/mL VEGF media or 5ng/mL FGF-2 in 
RPMI-1640 media supplemented with 10% FBS and 1% PS (Invitrogen). Following 24 hours, 
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cells were scraped off of the surface of the membrane and image analysis was performed with 
Sigmascan 4  to quantify the live cells that had migrated to the bottom of the membrane. These 
cells were also imaged with fluorescence microscopy. 
   
5.2.7 Histological staining  
Three samples from each experimental group were fixed in 10% NBF, coated in 4% agar, 
paraffin embedded and sectioned. Sections were stained with 4',6-diamidino-2-phenylindole 
(DAPI) to visualize cell nuclei or stained with Masson’s trichrome or Voerhof’s Van Gieson 
Staining to visualize ECM components.   Sections were imaged with light microscopy and 
captured with a digital camera (Nikon). 
5.2.8 Statistical analysis  
All data are presented as mean +/- s.e.m. Analysis of data was performed using SigmaStat 3.0. 
One-way analysis of variance (ANOVA) was performed followed by Tukey tests for pair wise 
comparisons. Data were considered statistically significantly different if p<0.05. 
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5.3 RESULTS  
5.3.1 Cellular proliferation  
In static culture, VEGF promotes significantly higher (p<0.05) BSMC proliferation than standard 
media alone or FGF-2 treated groups (Fig 5-4).  Under dynamic culture, there were no statistical 
differences amongst the stretch or static cycles in the FGF-2 or VEGF treated groups (Fig 5-5). 
The regular media treated group did not retain any attached cells when stretched during a 
preliminary experiment and therefore was not cycled as a control for the VEGF or FGF-2 treated 
groups.  This result was likely due to the cells on the surface of the SIS detaching with the 
application of mechanical stretch. Therefore, the DNA quantification of the dynamic cultures 
was nearly completely that of cells that had penetrated the SIS.  
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Figure 5-4. DNA quantification at 7 days growth factor treatment. n=6 per group. *,+ p<0.05 compared to all 
other groups except each other. 
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Figure 5-5. DNA quantification following 14 days culture with 7 days static growth factor treatment, 7 days no 
treatment static or stretched. Data are presented as mean +/= s.e.m, n=6 per group.  All VEGF groups and FGF-2 
groups are statistically significantly greater than the no growth factor treated group, p<0.01. 
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5.3.2 Cellular migration  
Histological analysis showed that in standard culture media BSMC remained on the surface of 
the SIS while both FGF-2 and VEGF profoundly promoted in-growth of the BSMC into the SIS 
(Fig 5-6). In the FGF-2 treated group the BSMC appeared to grow into the SIS in a cluster while 
in the VEGF treated group the cells were more spread throughout the tissue. In the transwell 
migration experiments, BSMC migrated more rapidly from one side of the culture insert to the 
other with the addition of the exogenous growth factors. (Fig 5-7) Futhermore, the exogenous 
growth factors  enhanced cellular migration into unoccupied space in the culture well with a 
significantly greater number of cells migrated in VEGF and FGF-2 than in standard media alone 
(Fig 5-7). 
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Figure 5-6. Top panel, DAPI stained nuclei (blue)  following 7 days with growth factor treatment on SIS. Bottom 
panel, light microscopy image of SIS cross section.  
 
 
 
Figure 5-7. DAPI stained cell nuclei at days 2, 4, and 7. Images are reduced from100x 
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Figure 5-8. Normalized cell nuclei counts on the unseeded side of transwell inserts at A. 2 days, B. 4 days, C. 7 
days. N=3 transwells per group with 5 images from each transwell analyzed. *p<0.01 compared to regular media 
controls. 
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At 14 days total culture time, there still appeared to be more cellular penetration of the 
BSMC into the SIS in the VEGF and FGF-2 treated groups compared to the regular media group 
in static culture (Fig 5-9 A-C). When constructs were cyclically stretched, there appeared to be 
fewer cells within the construct. However, upon further histological examination the cells were 
spread throughout the construct in the stretched groups (Fig 5-9, E-H) than in the static groups 
where the cells remained in the central portion of the SIS where seeding occurred (Fig 5-9 B,C). 
Furthermore, DNA quantification revealed that an equivalent number of cells were present in the 
constructs following stretch as in the statically cultured constructs (Fig 5-9).  In the FGF-2 
treated group under 0.5 Hz stretch, groupings of BSMC were seen to congregate in clusters 
which resembled rudimentary smooth muscle fascicles (Fig 5-9 H). This observation has been 
shown previously with the treatment of TGF-ß1 in bladders of rabbits [148] as well as in our 
laboratory’s previous work with the addition of TGF-ß1 to BSMC seeded on collagen gels 
(Chapter 4). Although there appear to be differences in the thickness of the samples in the 
histology, there were no measured differences in thickness of any of the samples with an average 
thickness of 120 µm. What appears to be thickness variability in the histological sectioning was 
due to artifact of the SIS spreading when sectioned.   
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Figure 5-9. Elastic trichrome staining of A. NG 14 day static B. VEGF 7 day NG 7 day static C. FGF-2 7 day NG 7 
day static D. Unseeded SIS E. VEGF 7 day Stretch 7 day 0.1 Hz F FGF-2 7 day Stretch 7 day 0.1 Hz G. VEGF 7 day 
0.5 Hz 7 day, H. FGF-2 7 day 0.5 Hz 7 day. Images are reduced from 200x. Scale bar represents 100 um. 
 
 
5.3.3 Collagen and elastin 
 In static culture, there was no significant change in collagen content between treatment groups. 
Under dynamic culture, collagen content in the tissue was significantly higher in the 0.5 Hz 
stretch group in both the VEGF and the FGF-2 treated groups compared to all other groups (Fig. 
5-10). In contrast, elastin content of the tissue was significantly higher in the 0.1 Hz stretch 
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group in both the VEGF and the FGF-2 treated groups compared to all other groups (Fig. 5-11). 
This elastin production was further confirmed with VVG staining (Fig 5-12) where black 
staining of elastin was apparent throughout the VEGF and FGF-2 treated tissues that were 
cycically stretched at 0.1 Hz. The unseeded SIS is shown in figure 5-12 A. Very small amounts 
of elastin were visible in the unseeded SIS.  Furthermore, with elastic trichrome staining elastin 
fibrils were only visible in the 0.1 Hz stretch groups.  
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Figure 5-10. Elastin protein concentration per gram wet weight of BSMC seeded SIS. Data are presented as mean 
+/- s.e.m. with n=6 per group. *indicates statistical significance with p<0.01 compared to all other groups. 
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Figure 5-11. Soluble collagen concentration per gram wet weight of BSMC seeded SIS. Data are presented as mean 
+/- s.e.m. with n=6 per group. *indicates statistical significance with p<0.05 compared to all other groups. 
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Figure 5-12. Verhoff’s Van Gieson staining of elastin fibrils (black) within: A. SIS, B. Seeded SIS treated with 
VEGF for 7 days stretched at 0.1 Hz for 7 days, C. Seeded SIS treated with FGF-2 for 7 days then stretched at 0.1 
Hz for 7 days. Black lines indicate presence of elastin. Images are representative from n=4 per group and are 
reduced from 400x. Scale bar represents 50 µm. 
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5.3.4 MMP activity and collagen in the media  
Within the first 7 days of static culture in media alone, VEGF, or FGF-2, bulk MMP activity 
remained constant with no significant differences among groups (Fig 5-13). Additionally, within 
the first 7 days of static culture, VEGF treated groups released a significantly greater amount of 
collagen into the media than FGF-2 treated groups or control (Fig 5-13). FGF-2 treated 
BSMC/SIS released significantly greater amount of collagen after 2 days in culture compared to 
control; however the FGF-2 group released a significantly lower amount of collagen into the 
media than control at day 4 (Fig 5-13). There was a visible change in the behavior of the BSMC 
on the SIS with the switch to regular culture media at 7 days in both the MMP activity and the 
amount of soluble collagen (Fig 5-13). 
During the second week of culture, MMP activity continued to increase in both the 
VEGF and FGF-2 groups (Fig 5-13). MMP activity became decreased with the addition of 0.5 
Hz mechanical stimulation in the VEGF treated group (Fig 5-13). The FGF-2 treated group as 
well as the VEGF treated group at 0.1 Hz remained constant until day 13 where it became 
significantly greater than the 0.5 Hz groups (p<0.05). The soluble collagen in the media became 
increased in the 0.1 Hz stretch groups compared to the values of the groups before stretch (Fig 5-
13). In the static culture groups the switch to regular culture media caused an increase in 
collagen in the FGF-2 treated group and a decrease in collagen in the VEGF treated group. These 
groups essentially returned toward a baseline level of collagen secretion by the BSMC in static 
culture. 
Summed totals of soluble collagen within the media showed that there was a significantly 
higher amount of collagen in the media in the 0.1 Hz group that was treated with VEGF for the 
first 7 days of culture (Figure 5-14). Summed totals of MMP activity at 14 days showed that 
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static culture with the addition of FGF-2 for 7 days followed by regular culture media for 7 days 
had significantly higher amounts of active MMPs released into the media than all other groups 
(Figure 5-14). Additionally, MMP activity was significantly lower at 14 days summed in the 
VEGF + 0.5 Hz group than all other groups except for the FGF-2 + 0.5 Hz stretch group (Figure 
5-14). 
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Figure 5-13. Top: MMP activity in collected media. Bottom: collagen in collected media. 
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Figure 5-14. Summed totals of soluble collagen found in media (top) and MMP-2 and 9 activity found in media 
(bottom) of BSMC seeded SIS. Data are presented as mean +/- s.e.m. with n=6 per group. * indicates p<0.05 
compared to all other groups. + indicates p<0.05 compared to all groups except FGF-2 at 0.5 Hz. 
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5.4 DISCUSSION 
5.4.1 VEGF and FGF-2  
The relative quantities of VEGF and FGF-2 added to the media were chosen based upon 
previous results in the literature wherein VEGF and FGF-2 were added to culture vascular 
smooth muscle cells to evoke a response [178]. These concentrations were also used in the ratio 
that they are released from the urothelium [142]. The response of the BSMC to the growth factor 
groups is similar to that found previously in co-culture of bladder urothelium with BSMC on SIS 
[94]. This finding further confirms a report that states that VEGF and FGF-2 are two key growth 
factors released by the urolthelium [142]. Furthermore, VEGF is a known promoter of 
mitogenesis and has been shown to increase proliferation in many cell types previously while 
FGF-2 has been shown to up-regulate collagen type III production in BSMC [179].  FGF-2 has 
previously been shown to decrease elastin mRNA expression in aortic smooth muscle cells 
[180]. No differences were seen in the present study between groups treated with FGF-2 or 
VEGF in terms of elastogenesis.  
Small differences were seen in MMP activity and collagen in the media. Additionally 
collagen production in the media during both the first 7 days and the last 7 days in culture varied 
dependent upon what growth factors were used. These differences demonstrate that the growth 
factor FGF-2 and VEGF impacted the cells during the first 7 days in culture and had persisting 
effects on the cells once the growth factors were removed from the system.  
While it would be scientifically interesting to combine growth factors and mechanical 
stimulation, the amount of growth factor necessary to add to the bioreactors would significantly 
increase the cost of the experiment. In the present study our primary use for the growth factors 
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was to promote in-growth of the BSMC into the SIS. Growth factors were not added to the media 
during the last 7 days of culture so that the effects of mechanical stimulation alone could be 
examined.  
5.4.2 Stretch protocols 
The stretch frequencies of the SIS were chosen to be non-physiologic and to be within a range 
found to promote mRNA expression of various ECM genes [69]. Additionally, the 0.5 Hz 
frequency has been shown by our laboratory to produce significant quantities of elastin in ex 
vivo organ culture (Chapter 2).  Interestingly, the large amounts of elastin production were seen 
in the 0.1 Hz stretched groups, but not in the 0.5 Hz stretched groups. This difference is likely 
due to the environment of the cells either being in an intact tissue or an actively remodeling piece 
of ECM scaffold. The amount of stretch “seen” by the BSMC in each of these cases may be 
different and will be the subject of future experimentation. Furthermore, it is possible that 
frequency and stretch ratios both play a role in the BSMC production of elastin and collagen. 
The SIS samples in the present study were stretched to 1.15 while the bladder strips in the 
previous study described in Chapter 2 were stretched to 1.20. The SIS samples were stretched to 
this lesser ratio due to the less compliant nature of the SIS compared with the urinary bladder 
wall.  
A previous study wherein BSMC were seeded on collagen and laminin coated flexcell 
TM plates examined varying stretch frequencies [69]. The study by Adam et al showed that 
collagen type I and III expression is dependent upon frequency of stretch [69]. However, in this 
study the authors only examined one stretch level of 20% in the maximal direction. Isenberg and 
Tranquillo showed that vascular smooth muscle cells produce small quantities of elastin when 
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cycled at 0.5 Hz at 5% stretch within collagen gels [137]. It is clear from these previous studies 
that the ECM production of the smooth muscle cell may depend on several factors of mechanical 
stimulation including time of stretch, stretch rate, and extent of stretch. A future study should 
examine the range of stretch protocols that trigger either collagen or elastin production in the 
BSMC.  
In static culture, increases in MMP -2 and -9 were not visible. This finding is in contrast 
to the increased MMP-1 activity found when MDSC are seeded on SIS [171]. This finding gives 
some insight into the kinetics of the MMPs. It is known that MMP-1 is a main collagenase that 
breaks down collagen type-I fibrils. It is likely that MMP-1 in the present study was increased 
early on in culture while MMP-2 and -9 (the gelatinases) had impact on breaking down the 
collagen further. The lower MMP activity in the summed total of 14 days culture in the VEGF + 
0.5 Hz stretch group corresponds to the VEGF + 0.5 Hz stretch group having a significantly 
greater amount of soluble collagen within the tissue. Increased amounts of collagen were found 
in the VEGF + 0.1 Hz group. The groups stretched at 0.1 Hz had increased elastogenesis within 
the tissue; however, there may have been collagen production in the VEGF group that was 
released into the media.    
5.4.3 Limitations  
It is common in utilizing exogenous growth factors to do the experiments in serum free or low 
serum media to gain biological impact of growth factors themselves. However, in the present 
study, the growth factors were utilized as an aid in order to promote enhanced penetration of the 
BSMC. Proliferation and enhanced cell survival were warranted to engineer a cellular construct 
for bladder wall repair. Therefore, the addition of serum during growth was necessary to 
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maintain high cell numbers in the construct, especially during the cyclic mechanical strain. The 
specific mechanisms by which the BSMC are coaxed to penetrate will be the focus of future 
studies. An additional limitation to this study as well as many similar studies utilizing and ECM 
scaffold in vitro was the difficulty in histological sectioning. Somewhat reasonable images were 
obtained by coating the fixed SIS strips in a solution of 4% agar prior to paraffin embedding and 
sectioning. This coating aided in the sectioning of the SIS with limited shredding of the thin 
collagenous material.  
 
5.4.4 Summary  
Both VEGF and FGF-2 promote ingrowth of BSMC into SIS under static and dynamic culture 
conditions. Dynamically cultured BSMC in the SIS matrix produce varied ECM dependent upon 
frequency of stretch. These findings may lead to more functional tissue engineered bladder wall 
replacements. 
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6.0   SUMMARY, IMPLICATIONS, AND FUTURE DIRECTIONS 
6.1 SUMMARY OF MAIN FINDINGS 
The main findings of the present study are summarized according to specific aim. The overall 
impact of this work is described in the following section 6.2.  
 
6.1.1 Specific Aim 1: Determine the effect of strain history on ECM remodeling of the ex 
vivo organ cultured bladder  
In the first aim of the present study our hypothesis was that abnormal strain frequency would 
promote ECM synthesis. We found that the bladder wall smooth muscle is capable of profound 
elastogenesis in response to mechanical strain. This finding was somewhat surprising in that the 
elastogenesis occurred in response to very rapid cyclicing (0.5 Hz) even though two other strain 
histories were explored. The two other strain histories (1 hr cycling and 8 hr cycling) are more 
physiologic in terms of large deformations that the bladder undergoes in vivo. Additionally in 
this aim, we found that the elastogenesis occurring at the 0.5 Hz strain history was also 
accompanied by greater quantities of collagen and active gelatinases released into the media. The 
results from this aim supported our hypothesis, that bladder wall remodeling of ECM is 
dependent on strain history. 
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6.1.2 Specific Aim 2: Examine the role of TGF-ß1 with and without cyclic stretch on 
bladder smooth muscle remodeling 
In the second aim of the present study hypothesized that TGF- ß1 will increase BSMC mediated 
ECM remodeling in the ex vivo organ culture by altering BSMC phenotype and that TGF-ß1 will 
increase BSMC mediated ECM remodeling of collagen gels. We found that the phenotype and 
remodeling response of BSMC both within cultured bladder strips and isolated and seeded on 
collagen gels was altered with the addition of TGF- ß1 to the culture media. We found that the 
phenotypic shift of the BSMC within the 0.5 Hz cycled bladder strips mimicked the SCI BSMC 
phenotype following 7 days of SCI. Furthermore, we found that the contractile phenotype of the 
BSMC was diminished with the addition of TGF-ß1 both within the cycled and static bladders as 
well as in the collagen gel experiments. This phenotypic shift was further confirmed by passive 
strip biomechanical testing whereby the bladder groups treated with TGF- ß1 were more 
compliant than all other groups. Elastogenesis was not impacted by the addition of TGF- ß1 to 
the culture media of cycled bladder strips; however, TGF-ß1 did increase soluble collagen 
production in the cultured bladders. Also, bladders cultured under mechanical stimulation of 0.5 
Hz were more mechanically compliant once decellularized than all other treatment groups 
indicating that the elastin produced may play a structural role in the bladders. Additionally, TGF-
ß1 increased collagen gel organization by promoting BSMC bundle formation and local physical 
remodeling. 
 
 146 
6.1.3 Specific Aim 3: Engineer a cell-ECM construct to further examine the effect of 
strain on BSMC remodeling with future applicability in tissue engineering the bladder wall 
In the third aim we hypothesized that cytokines VEGF and FGF-2 will promote cellular 
penetration into SIS and that non-physiologic strain histories will promote a similar response in 
the cell-ECM construct as demonstrated in organ culture. We found a method to improve 
migration of BSMC into SIS constructs by adding the exogenous growth factors VEGF and 
FGF-2 to culture. The migratory effect of the growth factors on the BSMC was confirmed using 
a Boyden chamber assay. Additionally, we were able to capture the elastogenic capability of the 
BSMC with cyclic mechanical stretching once the BSMC were integrated into the SIS 
constructs. Interestingly, large amounts of elastin were produced under cyclic at 0.1 Hz with 
15% stretch and not under 0.5 Hz 15% stretch as seen in the intact bladder strips. Stretching at 
the slightly faster frequency of 0.5 Hz promoted greater collagen production within the 
BSMC/SIS constructs. Within this aim we confirmed that mechanical stimulation may be used to 
manipulate the BSMC in a tissue engineered construct.  
 
6.2 IMPLICATIONS OF MAIN FINDINGS 
6.2.1 Implication for treatment of pathological bladders 
The findings in the first two aims of this study contribute to the body of knowledge of 
remodeling in the pathologic bladder, particularly in response to prescribed strain regimens and 
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the impact of one biochemical factor, TGF-ß1. These findings indicate that strain may be a key 
stimulus for remodeling seen in the bladder wall following SCI; however, it is important to note 
that strain history is particularly crucial to the type of remodeling that occurs by the BSMC 
within the bladder wall. Strain at a specific frequency induced large amounts of elastin 
production that were similar to that seen in the SCI bladder at 10 days. While these studies did 
not mimic a pathological condition explicitly, they give insight into the role of strain in elastin 
production within the bladder. Further experimentation would be necessary to explore the range 
of strain frequencies at which the BSMC produce elastin and how that range relates to the 
pathologic condition. 
Further impact of strain was seen in the change in phenotype of the BSMC within our 
cycled bladder strips and the phenotype of the SCI bladders at 10 days. The phenotype was 
shifted toward being more contractile in these bladders; however, with the addition of TGF-ß1 to 
culture the phenotype was shifted toward being more synthetic. This finding may be of particular 
importance in future studies in examining pharmacologic inhibitors of the phenotypic shift in 
order to prevent long-term fibrosis.  
6.2.2 Implication for mathematical modeling the remodeling of the urinary bladder wall 
Previous studies have shown that viscoelastic properties of the urinary bladder wall are altered 
following SCI  [7, 23]. These studies found that the SCI bladder exhibits significantly less stress 
relaxation than the normal bladder wall [23]. Furthermore, these studies showed that the 
mechanical properties of the bladder wall in the pathological state are highly interrelated to the 
structure of the bladder wall [112]. This structure function relationship is crucial in modeling the 
behavior of smooth muscle tissues like the bladder. Using in vivo data only, it is difficult to 
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assess the time-course changes in structure and biomechanical properties of the bladder tissue. 
The experimental models described in this study may be utilized to assess the affect of varied 
mechanical stimulation on the remodeling of the bladder wall ECM proteins. This data may be 
used in future studies in order to aid in the formulation of a mathematical model of remodeling in 
the pathological bladder and may additionally be of use to modeling other smooth muscle organs 
such as the esophagus and vasculature. 
 
6.2.3 Impact on tissue engineering urinary bladder wall replacements 
The greatest implication of the present study is in the field of tissue engineering. The third aim of 
the study showed the applicability of the information found utilizing ex vivo models of aspects 
of bladder pathologies. The ability of the BSMC to produce significant quantities of elastin may 
be utilized to engineer compliant smooth muscle tissues such as blood vessels, airway, or 
esophageal tissue. The specifics of how to control this elastogeneis and the organization of the 
elastin within the ECM still remain to be known. Also of importance to tissue engineering with 
biologic scaffolds is the ability to more rapidly engineer a tissue that may be mechanically 
stimulated with the addition of exogenous growth factors. To date, the lack of penetration of 
many cell types other than fibroblasts into biologic scaffolds such as SIS has been a time limiting 
factor. In order for engineered bladder wall replacements to be utilized in humans, the time it 
takes to grow the replacement needs to be minimized.    
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6.3 FUTURE STUDIES 
6.3.1 Examining remodeling in augmented smooth muscle tissues 
The present study provides a basis for many future studies involving tissue engineering and the 
remodeling process that occurs in augmented tissues. The cell/ECM interactions within bladders 
replaced partially or fully with an acellular or cell seeded biological scaffold, such as SIS that 
was used in the present study or urinary bladder matrix (UBM), are currently unknown.  The 
dynamic organ culture experimental set up from aims 1 and 2.1 may be utilized to explore the 
augmented bladder in a controlled in vitro system. Seeded or unseeded portions of SIS or UBM 
may be sutured into strips of urinary bladder wall and set up in the strip biaxial bioreactor 
(Figure 6-1 and 6-2). These augmented bladder strips may then be mechanically stimulated at 
varied strain protocols that may mimic normal bladder filling and voiding. After set periods of 
culture time, the augmented strips may be assessed using methods described in the present study 
to examine cellular penetration, proliferation, collagen synthesis, and elastogenesis. Additionally 
cell phenotype may be explored as well as passive mechanical testing to examine BSMC tone. 
These studies will be valuable in understanding how engineered tissue constructs are maintained 
and remodeled by the surrounding native tissue. This information may then be utilized in vivo to 
improve upon animal models of bladder wall replacement. 
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Figure 6-1. Organ culture preparation. A. Bladder wall divided with UBM sutured in between the two halves B. 
Schematic of uniaxial bioreactor set up with UBM augmented bladder strip. 
 
 
Figure 6-2. UBM sutured in between 2 halves of a rat bladder strip. The bladder strip was prepared with stainless 
steel spring grips attached to the longitudinal ends (original length 10 mm), it was then cut in half and a piece of 
UBM (8 mm) was sutured to each edge. Arrows show interface between UBM and bladder wall. 
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6.3.2 Examining regulation of elastogenesis and phenotypic shift in the BSMC 
Of additional importance in future work are basic studies on the cell and molecular level to 
understand the regulation of elastogenesis in response to mechanical stimulation as well as the 
role of phenotypic shift of the BSMC in the pathological bladder. Specific molecular regulation 
of elastogenesis is not currently understood outside of development. It is at present unclear what 
the role of mechanical forces is during development of elastin.  There are many pathways that 
are mechanosensitive in smooth muscle cells. Several of these pathways have been examined 
primarily in vascular SMCs. However, the BSMC appear to have the unique ability to promote 
elastogeneisis in response to mechanical stimulation that VSMC do not possess. Future studies 
could begin to address understanding of BSMC elastogenesis by doing comparative studies with 
VSMC or other SMC cell types to assess triggers of elastin production.  
It remains unclear what the precise biophysical and biochemical stimuli are for 
phenotypic shift in the bladder following SCI. The present study examined one biological factor 
that is known to be up-regulated in the SCI bladder and fount it to impact cells to switch to a 
synthetic phenotype. However, there are a wide range of molecules that may influence this shift. 
One potentially fruitful study would be examining the role of IGF-1 on BSMC phenotype and 
remodeling abilities. IGF-1 was another up-regulated molecule following SCI [35].  The time 
course of the molecular signaling events during the remodeling process may be the subject of 
future studies and would go a long way in regulating remodeling in the bladder following SCI for 
optimal bladder function. 
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6.3.3 BSMC response to contact guidance and cyclic mechanical stretch 
In order for a smooth muscle tissue to produce functional contractile forces, it must possess 
proper architecture of the BSMC as well as the collagen and elastin components of the ECM. To 
date, many tissue engineering (TE) approaches for bladder wall reconstruction have had some 
success engineering smooth muscle tissue for bladder wall replacement, though few techniques 
have made it to human patients. Among the most successful are autologous cell-based and 
include seeding on either a biodegradable polymeric scaffold [138] or on a xenographic 
decellularized matrix such as small intestinal submucosa (SIS) [140] or bladder acellular matrix 
(BAM) [100]. Additionally, smooth muscle cell sheets grown on temperature sensitive polymers 
have been explored as scaffold free approaches with promising results in vivo [181]. These 
current cell sheet approaches are an improvement over single cell suspension or scaffold-based 
approaches due to their ability to retain cell-cell interactions; however, they do not allow for 
proper nutrient diffusion and lack the mechanical stability and organization of both SMC and 
ECM that is necessary for a functional bladder wall. These current TE based technologies for 
bladder wall repair result in incomplete, disorganized tissue regeneration. One possible reason 
for these shortcomings is that most TE approaches for the bladder wall give little regard to SMC 
and ECM alignment or interaction prior to implantation. In order to engineer functional bladder 
wall smooth muscle, one must understand the bladder SMC/ECM interactions and development. 
In the current study, we isolated BSMC from a bladder biopsy and utilized contact guidance, via 
a microgrooved substrate, and mechanical stimulation during SMC tissue culture to align our 
contiguous sheet of bladder smooth muscle. 
Microgrooved PDMS was able to be fabricated with uniform grooves of varying 
dimensions (Fig 6-3). These grooves provided contact guidance for the bladder SMCs and 
 153 
promoted alignment (Figure 6-3,4). Narrower grooves led to qualitatively higher alignment of 
bladder SMCs. Bladder SMCs exhibited collagen and elastin production on flat as well as 
microgrooved surfaces. Cyclic uniaxial stretch led to more proliferation than static culture 
exhibited by a statistical increase in DNA content from the cell lysates. Elastin was decreased at 
0.5 Hz uniaxial stretch compared with biaxial stretch (Figure 6-5). Collagen was found to be 4 
fold higher (p=0.013) in the mechanically stretched samples than in static culture after 5 days 
(Figure 6-6). The stained F-actin of uniaxial mechanically stimulated samples shows a 
preferential orientation of the BSMC perpendicular to the direction of strain (see Chapter 1). 
 
 
Figure 6-3. Scanning electron microscopy of BSMC on alternating 100 µm grooves (A) and 10 µm grooves with 100 
µm raised in between (B), depth of all grooves was 5 µm. 
 
 
 
Figure 6-4. Bright field microscopy of overgrown BSMC on alternating 100 µm grooves (A) and 10 µm grooves 
with 100 µm raised in between (B), depth of all grooves was 5 µm. 
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Figure 6-5. Elastin deposition onto silicone under static, uniaxial, and biaxial stretch. n=4 for static and uniax, n=3 
for biax in 0.5Hz group n=1 for 1Hz group; * p<0.05 
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Figure 6-6. Collagen deposition onto silicone surface under static, unaixial, and biaxial contiditions. n=3 or 4 for 
each group, *p<0.05 
 
This study examined methods to grow BSMC in a physically and mechanically 
controllable environment with the aim to promote BSMC alignment and ECM production. The 
use of PDMS microgrooves provided necessary contact guidance for the bladder SMC 
organization. In this study, we also have verified that uniaxial stretch of bladder smooth muscle 
cells results in alignment perpendicular to the direction of strain. We have also found that cyclic 
uniaxial stretch results in higher collagen production than static culture. It is known in the 
literature that cyclic mechanical stretch to bladder smooth muscle cells results in increased 
collagen synthesis; however, most of these studies use commercially available devices that 
produce anisotropic non-reproducible stretch. Through the use of our biaxial stretch bioreactor, 
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we were able to controllably mimic normal and increased micturation cycles over 48 hours. 
Future experiments need to be performed investigating a wider range of stretch frequency, longer 
time periods, and the effects of stretching the bladder SMC on the grooved PDMS surfaces both 
uni- and biaxially. This study showed that isolated cell experiments may also be valuable in 
examining the effects of strain on ECM production as well as engineering organized sheets of 
BSMC. 
6.3.4 Summary of future directions 
This section outlined studies that may be performed on both the tissue level, cell level, and 
molecular level. There are clearly a multitude of questions that may be asked on all of these 
levels of how the BSMC are prompted to penetrate scaffolds, remodel tissues, and change 
cellular phenotype and alignment. Understanding BSMC remodeling in response to strain is 
important both macroscopically in the behavior of the tissue as well as microscopically in the 
behavior of the cells and signaling pathways.  
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APPENDIX A 
BSMC RESPONSES TO CONTACT GUIDANCE AND CYCLIC MECHANICAL 
STRETCH - METHODS 
A.1 METHODS  
A.1.1 Microgroove fabrication 
Polydimethylsiloxane (PDMS) microgrooves were fabricated using soft photolithography. 
Briefly, a mask was fabricated with 4, 1.5 cm x 1.5 cm, groove patterns. These patterns were 
deposited onto a silicon wafer using negative photoresist and UV exposure. PDMS was mixed, 
degassed, and poured onto the patterned silicon wafer. The wafer coated in PDMS was baked at 
60°C for 2 hours and incubated at room temperature overnight. The PDMS was then peeled off 
of the wafer using forceps. The microgrooves resulting from this processing were ranging from 
100-1000 µm long, 10-200 µm wide, and 2-10 µm high. The patterned side of the PDMS was 
exposed to UV light for 12 hours, then it was rinsed 1x in DIH2O, and 2x in HBSS.  
 158 
 
Figure A-1. Photolithography process. 
A.1.2 Cell isolation and seeding 
The smooth muscle cells were isolated from the bladders of normal Sprague-Dawley rats (170 – 
250g) according to the methods adapted from the literature [165].  Briefly, under sterile 
conditions the bladder was cut open and pinned down on silicone-bottomed dissection Petri dish 
with the luminal side up.  Under the dissection light microscope, the mucosal layer was 
mechanically removed from the rest of the bladder using fine forceps and scissors.  The 
remaining smooth muscle layer was minced into small pieces and incubated in a 10mL beaker 
containing RPMI 1640 (Invitrogen, Carlsbad, CA) medium supplemented with collagenase (1 
mg/mL; Sigma, St.Louis, MO), and trypsin (Invitrogen) (0.025%) with gentle spinning at 37 °C 
for 30 minutes.  The cell suspension was passed through 100-µm cell strainer and centrifuged at 
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1,000g for 5 minutes to remove collagenase/trypsin; the pellets were resuspended in RPMI 1640 
medium supplemented with 10% fetal bovine serum (Hyclone, Logan, UT) and cultured in 
tissue-culture polystyrene dishes.  All smooth muscle cells were cultured under standard cell 
culture conditions (sterile, 37 °C, humidified, 5% CO2 / 95% air environment) and were used in 
experiments at low (up to 8) passages.  SMC isolated from rat bladders were seeded 100,000 
cells/cm2 onto the patterned and non-patterned PDMS. 
A.1.3 Cyclic stretch 
Rat bladder SMCs were seeded on PDMS in static culture for 4 days. Then, samples were affixed 
to stretch bioreactor rods via tissue grip springs fabricated in our laboratory. Half of the samples 
were exposed to 10% uniaxial cyclic stretch at 1 Hz in a tension bioreactor for an additional 48 
hours. The other half of the seeded samples were exposed to 10% biaxial cyclic stretch at 1 Hz in 
a custom-made biaxial stretch bioreactor (Fig. A-2) for an additional 48 hours. Following 
stretching protocols, samples were removed for imaging and biological assays.  
 
 
Figure A-2. Biaxial stretch bioreactor. A. Bath with 4 grips and silicone sample, B. Running bioreactor with 4 
linear actuator motors 
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A.1.4 Scanning electron microscopy 
Samples were fixed in 2.5% gluteraldehyde, rinsed in PBS, soaked in 1% OsO4, and dehydrated 
in EtOH. Samples underwent critical point drying and sputter coating. Then, samples were 
viewed with a JSM6330F Scanning Electron Microscope in order examine initial cell attachment 
and alignment with respect to microgrooves. 
A.1.5 Biological assays 
In order to examine cell proliferation, a PicoGreen dsDNA quantitation kit (Molecular Probes, 
Eugene, OR) was used on cell lysates according to the manufacturer’s instructions. The primary 
components in the bladder ECM are Collagen I and III and elastin. Based on techniques adapted 
from Brown et al [128] total collagen was extracted from samples using a solution of 0.5 M 
acetic acid (Sigma) and pepsin (1 mg/ml Pepsin A (P-7000); Sigma). Each sample was placed in 
a microcentrifuge tube and incubated in 1 ml of extraction solution overnight ( 16 h) on a 
rocker table (Orbitron Rotator I™; Boekel Scientific, Feasterville, PA) operating inside a 
refrigerator at 2–8°C. Elastin was extracted using a hot oxalic acid treatment. The concentrate 
was then resuspended in cold (<5°C) Elastin Precipitating Reagent (Fastin™ assay kit, Biocolor 
Ltd., Newtownabbey, N. Ireland). Following the extraction steps, the collagen and elastin 
extracts were assayed according to the guidelines provided with the Sircol™ and Fastin™ assay 
kits, respectively (Biocolor Ltd., Newtownabbey, N. Ireland) using a Genesys 20 
spectrophotometer (Thermo Spectronic, Rochester, NY). 
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A.1.6 Statistical analysis 
All assays were analyzed with a statistical software package (SigmaStat) using ANOVA with 
p<0.05 considered significant. 
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